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Abstract 
 
Combination of hyperthermia and radiation brachytherapy has been shown to be effective for 
treatment of a tumor. After increasing the temperature, the tumor becomes sensitive to radiation 
dose, and as a result the radiation dose can be reduced. 
The purpose of this study was to identify the appropriate antenna array which can be effectively 
used on a deep-seated breast tumor to increase the temperature to more than 42.5˚C, and to examine 
the effect of a smaller cumulative radiation dose of 30 Gy.  
In this research different antenna and its parameters are tried and it was found coaxial-slot 
antenna array to be the most appropriate for applying hyperthermia on a deep-seated breast tumor. 
The temperature distributions were measured with a breast phantom, and specific absorption rate 
(SAR) distributions were calculated using a simulation software. Coaxial-slot antenna array, 
consisting of two coaxial-slot antennas, separated by a distance, and using a microwave power of 
15 W increased the temperature of a tumor phantom, in an area of 30 mm in diameter, to over 
42.5˚C in 30 min. The temperature as well as SAR were observed to have increased more in the 
tumor tissue than in the other types of tissues which were tested. Thereafter, we have examined 
the radiation dose distribution of brachytherapy using a treatment planning software. Simulations 
were conducted on the Computed Tomography image of an anonymous breast tumor patient; the 
tumor’s dimensions were 40 mm (length) × 30 mm (width). A radiation dose of 30 Gy given in 5 
fractions of 6 Gy each, which is lesser than the conventional radiation doses used in external beam 
radiation therapy, was applied to the tumor. Harm to adjacent tissues is also expected to be 
minimized due to lower radiation dose.  
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As a result of this study, there is a possibility of local control of deep-seated small breast tumors 
using a combination of interstitial hyperthermia by using coaxial-slot antenna array to increase the 
temperature to over 42.5˚C and radiation brachytherapy by applying cumulative dose of 30 Gy. 
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Chapter 1 
 Introduction 
 
Cancer is a collection of related diseases in which some of the body’s cells begin to divide without 
stopping, and spread into surrounding tissues [x]. It is a generic term for a large group of diseases 
that can affect any part of the body, which is made up of trillions of cells. Normally, human cells 
grow and divide to form new cells as the body needs them. When the cells grow old or become 
damaged, they die, and new cells take their place. This orderly process breaks down when cancer 
develops. Many cancers form solid tumors, which are masses of tissue. Cancerous tumors are 
malignant, which means they can spread into, or invade, nearby tissues. This latter process of 
cancerous cells invading adjoining parts of body is referred to as metastasizing. Metastases are a 
major cause of death from cancer. 
Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 
million new cases in 2012 [1]. The number of new cases is expected to rise by about 70% over the 
next 2 decades. Cancer is the second leading cause of death globally, and was responsible for 8.8 
million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer [1]. 
Breast cancer is the formation of a malignant tumor that has developed cells in breast. Breast 
cancer continues to be one of the most common cancers and a major cause of death among women 
worldwide.  
In Japan, the number of projected breast cancer incidence in 2016 is 90,000 [2].  
Figure 1 shows the statistics of projected breast cancer incidence and other cancer incidence in 
Japan in the year of 2016 [2].  
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Figure 1.1 Projected cancer incidence in Japan in 2016 
Figure 2 shows the statistics of projected number of cancer deaths due to breast cancer along with 
other major cancer deaths. Projected number of deaths due to breast cancer in 2016 is 14,000.  
 
Other: 
165,600
Breast:
90,000
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Lung, trachea: 
43,200
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30,200
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Figure 1.2 Projected number of cancer deaths in 2016 
 
1.1 Composition of a Breast  
Breast is composed of various tissues [3], such as fibro glandular, fat, muscle tissues. The shape, 
size and ratio of different tissues vary from person to person. A mass of glandular, fatty, and 
fibrous tissues over the pectoral muscles of the chest wall are attached by fibrous strands. A 
layer of fatty tissue surrounds the breast glands and gives the breast a soft consistency. 
The glandular tissues of the breast house the lobules, which are milk producing glands, toward 
the nipple and the ducts which are milk passages. Toward the nipple, each duct widens to form 
a sac called ampulla. During lactation, the lobules produce milk. Once milk is produced, it is 
transferred through the ducts to the nipple. 
To summarize, the breast is composed of: 
 Lobules or Milk glands 
 Ducts or milk passages 
 Nipple 
 Areola  
 Fibro glandular tissue  
 Fat 
 Muscle 
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The content of fat and fibro glandular tissue varies from person to person. This makes the 
diagnosis or treatment of breast related illness difficult. 
Figure 1.3 shows the image of a breast emphasizing different components of it. 
 
 
Figure 1.3 Image of a breast showing different parts (1) 
 
In this research work, microwave is applied inside the breast. Microwaves are a form of 
electromagnetic radiation. A microwave’s interaction with the tissues in human body cause the 
wave’s amplitude to change its amplitude as it propagates through the tissues. 
 
1.2 Electrical Properties of the Tissues Present in Breast 
Research on  the electrical properties of the human body tissues at microwave frequency range 
of 300MHz- 300GHz has been extensive. The electrical properties are represented in terms of 
relative permittivity and conductivity.  
Studies revealed that the permittivity of the tissues are highly dependent on the water content 
[4]; tissues with low water content , such as fat have lower permittivity than tissues like muscle, 
skin and tumor tissues [4]. While permittivity gives us the indication of the tissue’s ability to 
absorb microwave energy, conductivity on the other hand gives the indication of the loss or 
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attenuation of the microwave signal. Therefore, as the microwave signal travels through 
different tissues in the breast it suffers both attenuation and reflection as it encounters. 
Understanding the electrical properties and heterogeneous nature of a female breast is 
important as it helps in the creation of a more realistic either numerical or physical breast 
phantom that can be used to assess the efficacy of any microwave technologies for treatment 
of cancer. Measurements of the tissue’s electrical properties depend on a number of factors 
such as: tissue density, temperature, water content, location in the  breast etc. 
As this research work was conducted on a 2.45GHz frequency, the dielectric properties of the 
tissues were considered accordingly [5].  
Table 1.1 shows the dielectric constants, namely the relative permittivity and conductivity of 
the tissues used for this research work. 
Table 1.1. Dielectric constants of different tissue phantoms 
 
Parameters Relative Permittivity Conductivity (S/m) 
Skin 72.9 0.49 
Fat 56.9 0.30 
Muscle 66.0 0.71 
Fibro glandular  68.8 0.79 
Breast tumor 79.2 0.80 
 
1.3 Breast Cancer Symptoms and Risks 
In a patient suffering from bearing breast cancer, the cells surrounding the tumor are affected and 
in a span of time the tumor  can damage the normal breast tissues of the human body. Major 
symptoms include an indication of red marks around the breast, discharge of blood from the nipples, 
nipple turning inward, formation of a lumpand pain in the breast. The following are the known risk 
factors and causes of breast cancer [1]: 
 Risk of breast cancer is higher in women whose close relatives have (or have had) 
a breast cancer [1]. 
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 Abortion- Risk of breast cancer is higher in women who have had an abortion at an 
young age [1]. 
 Age: Risk of breast cancer increases with age. Women at the age of 50-64 have a 
higher risk [1]. 
 Weight: Risk of breast cancer is higher in women who are overweight [1]. 
1.4 Types of Breast Cancer 
Breast cancer can start in different areas of the breast- the ducts, the lobules or in the tissue in 
between. Following are few of the different types of breast cancer [6]. 
 
 Ductal carcinoma in situ:  Carcinoma refers to any cancer that begins in the skin or 
other tissues that cover internal organs — such as breast tissue. In situ or “in its original 
place” means that the abnormal growth remains inside the lobule and does not spread 
to surrounding tissues. This is most invasive type of non-invasive breast cancer. This 
type of cancer starts inside the milk ducts that cover or line the internal organs,  this 
does not spread beyond the milk ducts into any normal surrounding breast tissues. 
 Invasive ductal carcinoma: This is a common type of breast cancer. This  begins in the 
milk ducts and spreads to the surrounding breast tissues.  
 Lobular carcinoma in situ: Lobular carcinoma in situ (LCIS) is an area (or areas) of 
abnormal cell growth that increases a person’s risk of developing invasive breast cancer 
later on in life. Lobular means that the abnormal cells start growing in the lobules, the 
milk-producing glands at the end of breast ducts. People diagnosed with LCIS tend to 
have more than one lobule affected. 
 Invasive lobular carcinoma: This type of cancer develops in milk-producing lobules, 
spreads into the ducts that carry milk to the nipple, and later also spreads to the 
surrounding breast tissues. 
 Inflammatory breast cancer: This type of cancer normally starts with the reddening and 
swelling of the breast instead of a distinct lump. It tends to grow and spread faster than 
the other types of breast cancer. 
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 Male breast cancer: Breast cancer in men is a rare disease. When men bodies synthesize 
breast developing hormones and have abnormal hormone levels, breast cancer may 
occur.  
 Molecular subtypes of breast cancer: There are five different molecular subtypes of 
breast cancer. 
(i) Luminal A:  It is hormone-receptor positive, HER2 negative and has low levels 
of the protein Ki-67, which helps control how fast cancer cells grow.   
(ii) Luminal B: This type of breast cancer generally grow faster than luminal A and 
their prognosis is slightly worse than them. This is also hormone receptor and 
any extreme level of HER2  with high level of Ki-67. 
(iii) Triple-negative/Basal-like: This type of cancer is commonly seen in women 
with BRCA1 gene mutations. This type of breast cancer is hormone receptor 
negative and HER2 negative. 
(iv) HER2-enriched. As name suggest, this type of cancer is HER2 positive. This 
type of cancer is treated with targeted therapies aimed at HER2 proteins. 
(v) Normal-like: This type of cancer grows slowly. This cancer is hormone-
receptor positive and HER2 negative. 
 Paget’s disease of the Nipple: Paget's disease of the nipple is a rare form of breast 
cancer in which the cancer cells collect in or around the nipple. The cancer usually 
affects the ducts of the nipple first (small milk-carrying tubes), then spreads to the 
nipple surface and the areola (the dark circle of skin around the nipple). The nipple and 
areola often become scaly, red and itchy, and irritated. 
 Phyllodes tumors of the breast: This type of cancer tend to grow quickly but rarely 
spread outside the breast. Most of the cancer of this type are benign.. 
 Recurrent and metastatic breast cancer: Recurrent breast cancer is a type of cancer 
which comes back to another breast or chest wall after a period of time. On the other 
hand, metastatic breast cancer is a type of cancer which spreads to other parts of the 
body.  
Both these types of cancers are considered as advanced stage cancers. 
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1.5 Different Types of Treatment Modalities 
Different types of modalities or the combination of two or three modalities are used to treat 
breast cancers [7]. Following are some of the modalities used commonly: 
1.5.1 Surgery 
Surgery is a common treatment for breast cancer, and its main purpose is to remove the 
cancer as much as possible. There are two main type of surgery is done. 
Breast Conserving Surgery: In this kind of surgery, only a part of the breast containing 
the cancer is removed.  Figure 3 shows the procedure to detect the area before breast 
conserving surgery. 
The patients who opt for breast conserving surgeries, in most cases, opt for radiation 
therapy or chemotherapy after the surgery. . 
 
 
 
 
Figure 1.4 Breast Conserving Surgery- lumpectomy 
 
 
 
 
 
 
9 
 
Mastectomy: In this kind of surgery, the entire breast is removed, including all of the 
breast tissue and in some cases, other nearby tissues.  
 
 
Figure 1.5 Breast mastectomy surgery 
 
 
1.5.2 Chemotherapy 
Chemotherapy is a treatment using cancer killing drugs that may be given intravenously or 
orally. In most of the cases, it travels through the blood stream and reaches the cancer cells 
to destroy them. Chemotherapy can be given before or surgery. 
Before Surgery: Chemotherapy is done before the breast conserving therapy.  
After Surgery: In most of the cases,, chemotherapy or a combination of chemotherapy 
and radiation therapy is given to the breast after surgery. After breast conserving surgery, 
few cells remain in the lymph node or other tissues, stay back. In order to kill those cells, 
chemotherapy or a combination of chemotherapy and radiation therapy is given. 
1.5.3 Radiation Therapy 
In radiation therapy, high energy particles are used in order to kill the cancer cells. 
Radiation therapy for breast tumor is done after surgery. Radiation therapy can be done in 
various ways: 
External Beam Radiation Therapy: In this case, the whole breast gets irradiated with 
high energy particles. Radiation therapy is usually done after the surgery. External beam 
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radiation therapy is given in order to kill cancer cells which have spread in many different 
areas of the breast. 
Figure 1.6 shows the procedure how the whole breast gets irradiated. 
 
 
Figure 1.6. Breast tumor treated by external beam radiation therapy 
 
 
Internal Beam Radiation Therapy: Internal radiation is a form of partial breast radiation. 
During the treatment, a radioactive liquid is injected using needles, catheters etc., in order 
to target the area. 
Breast Brachytherapy: In breast brachytherapy, catheters are placed inside the breast to 
deliver the breast at the time of the surgery or shortly thereafter which carries targeted 
radiation to the tissue where the cancer originally grew.  
Figure 1.7 shows the procedure for breast brachytherapy. 
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Figure 1.7 Brachytherapy procedure for breast with tumor  
 
 
1.5.4 Hyperthermia 
Microwave-hyperthermia is a method of treating cancer by heating the tumor. In this 
method, the tumor temperature is increased by an external means to over 42.5˚C. At this 
temperature, the cells behave cytotoxic and as a result, the cells die or become sensitive 
to radiation.  
Many methods of hyperthermia treatment are available. Hyperthermia may be local, 
where only a small restricted area of the body is heated, or it can be regional, where an 
entire body part may be heated, or whole body may be heated. Techniques that have been 
used for production of hyperthermia include conduction through the skin, recirculation of 
externally heated blood, heated intravenous fluids, ultrasound, and electromagnetic 
coupling modalities. These electromagnetic methods may be invasive or non-invasive 
depending on the location of the tumor. 
The main challenge in treating cancer with hyperthermia is the technologies used in 
different experiments, cannot deliver effective and homogenous heating of all sites, 
particularly the deep seated tumors. 
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1.5.5 Combination Therapy 
Recently, different types of combination therapies are being practiced.  for treating breast 
tumors.  
Combination therapies are given in order to achieve better results in treatment of  cancer 
cells, lesser use of radiation therapy, given and to prevent reoccurrence of cancer cells. 
Depending the breast cancer stage, tumor size, proliferation rate and other condition such 
as metastases, the combination of different modalities of breast cancers are chosen. For 
stage I and II breast cancer, combination of breast conserving therapy and radiotherapy is 
mostly used [7]. The highest percentage of the breast cancer are treated with mastectomy 
surgery, radiotherapy and chemotherapy [7]. This whole process takes long time and 
observation regularly. Radiotherapy can be delivered by either external beam radiation 
therapy or brachytherapy. Depending on the patient history, tumor size and metastases, 
the radiation dose gets decided. As discussed earlier, there are two types of surgery for 
breast cancer common. Depending on the type of surgery and metastases the radiation 
dose is decided. Most commonly breast cancer is stage II and the radiation dose for that is 
mostly given 50 Gy- 60 Gy [46].  
In this research, the cumulative radiation dose is proposed 30 Gy which is comparatively 
lesser than the conventional dose   
 
In this current research work, combination therapy of hyperthermia and breast 
brachytherapy is investigated. The detailed research work is described in the theses. 
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1.6 Literature Survey 
Combination of microwave hyperthermia and radiation therapy has been a topic of interest for 
many researchers for the past several decades.  
 In 1977, Dewey et al, investigated the cellular responses of the combination of hyperthermia 
and radiation [8]. The main advantages of applying hyperthermia as a cancer therapy from 
cellular point of view are:  
(a) During cell cycle, the cells are relatively radio-resistant in the S phase but they are sensitive 
to hyperthermia. So the cells in S phase can be radio-sensitized by combining hyperthermia 
and X-irradiation; the tumor cells which would normally survive radiation dose alone, can 
thus be killed by combining hyperthermia and radiation. 
(b) Tumor hypoxia is the situation where tumor cells are deprived of oxygen under such 
hypoxic conditions, it has been shown that cell obtain radio resistance [x2]. Such relatively 
radio-resistant cells in the tumor may be destroyed by combination of hyperthermia and x-
irradiation. 
In 1980, Raymond et al, investigated about the microwave induced local hyperthermia in 
combination with radiotherapy particularly in human malignant tumors  [9]. This study had 
shown microwave hyperthermia can be used in conjunction with radiation for clinical benefits. 
The results of the combination therapy were positive, and the harm to the surrounding tissues 
were less as the heating and radiation. 
Simultaneous application of hyperthermia and radiation therapy has also examined by many 
researchers. In some cases, hyperthermia is applied before radiation therapy; sometimes it is 
applied along with the radiation therapy and sometimes it is applied after the radiation therapy. 
In 1978, Overgaard et al, examined the effect of applying the therapies sequentially. During 
the experiments, a temperature of 42.5˚C was achieved in 60 min [10]. The results were 
compared to the effect of applying the therapies simultaneously. A decrease in thermal 
enhancement ratio (The synergistic effect of heat and radiation is quantified by thermal 
enhancement ratio) with increasing interval between the treatment modalities. For 
hyperthermia given after radiation, there was a marked reduction in thermal enhancement ratio 
within the first hour. With hyperthermia given before radiation, the reduction in the thermal 
effect with increasing time interval was less pronounced, and there was an increase in thermal 
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sensitization The rapid recovery from excess thermal damage to the skin when radiation was 
given before hyperthermia has implications for the therapeutic ratio. But for all intervals tested 
except 24 hours, the thermal enhancement ratio for the skin was only slightly below that 
observed in the tumor and did not result in any significant improvement of the therapeutic ratio. 
With the 24 hours interval, the thermal enhancement ratio for tumor was significantly higher 
than that of normal tissue, and a slight therapeutic gain was obtained. However, the 
improvement in therapeutic gain was more impressive for radiation given before hyperthermia.  
Research result had shown that increasing the interval between radiation and hyperthermia 
resulted in an improvement in the therapeutic gain reaching a maximum at an interval of 4 
hours.  
Patients with persistent and/or recurrent breast tumors or chest wall tumors have significantly 
benefited when hyperthermia has been added to their radiotherapy and/or chemotherapy 
regimens [10-19]. One of the reasons for the success of hyperthermia in this group of patients is 
the superficial location of the tumor. Superficial lesions are the least difficult to heat adequately 
because of their accessibility and proximity to external energy sources. The composition of the 
local anatomy may also contribute to better heating [20, 21]. Another possible reason may be that 
superficial lesions are more amenable to invasive thermometry and thermal mapping of 
temperature sensors, thus providing more temperature feedback data during the treatment, 
which can be used to improve heat delivery and ensure treatment quality [22, 23]. Clinical 
research efforts have demonstrated that the response of cancerous tumors to sequential 
thermoradiotherapy (i.e., sequentially combined radiotherapy and hyperthermia) is well 
correlated with power deposition coverage and/or thermal dose coverage [17, 23-33]. These 
studies have also pointed to the challenge of consistently achieving biologically meaningful 
thermal doses in 100% of the target volume (total tumor area) in routine clinical practice. 
Therefore, it is widely accepted that the benefits of hyperthermia as an adjunct to radiotherapy 
can be significantly augmented with improvements in treatment delivery techniques, better 
heating technology, advances in treatment planning and implementation of quality assurance 
guidelines [23-27]. Moreover, in vitro and animal studies have shown that when hyperthermia 
and radiation are administered simultaneously —rather than sequentially as it is conventionally 
done—heat induced radio sensitization is increased at thermal doses achievable in the clinic 
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[38-41]. For instance, mild hyperthermia—41°C maintained for ~60 minutes—produces heat 
induced radio sensitization if radiation and heat are delivered simultaneously, but not 
sequentially. This is significant because a minimum target temperature of 41°C is more 
clinically achievable than the > 42°C needed to produce heat induced radiationwith sequential 
treatment [39, 41-42]. In 1983, Ronald et al, reported clinical research study where hyperthermia 
in combination with radiotherapy was used for superficial tumors [43]. The heating was 
observed 3 cm deep under the skin layer. The tumor temperature was increased to around 43˚C-
44˚C.  
Although a phase III clinical trial conducted by Emami et al. (1996) had concluded that there 
are no beneficial effects of the combination of interstitial hyperthermia and radiation therapy 
as compared to radiation therapy alone, limitations in the quality of hyperthermia due to 
inadequacy of technologies available at that time, was mentioned to be a challenge [44].  
It is also reported that the combination of hyperthermia and radiation therapy can reduce the 
tumor growth. In 2005, Clare et al, had concluded that combined hyperthermia and external 
beam radiation therapy increased animal survival compared with either of the treatments alone 
[46]. This study was done on rat breast models and was limited to tumors having a diameter of 
2.5 cm or less. The study had shown the evidence of the histo-pathologic sections of the tumor 
after 7 days of the surgery. There was no other side effects observed. This research group had 
also noted that a radiation dose of 20 Gy or more along with hyperthermia increases the chances 
of end survival and/or local cure. These findings suggested a dose related effect of radiation 
therapy and possibility of optimization between the temperature rise and radiation therapy. 
As the previous studies shown the difficulty in heating the human tissue properly and in 
monitoring the temperature rise, some researchers came up with different microwave antennas 
for hyperthermia.  
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There are normally two ways practiced by different researchers for hyperthermia:  
(1) Ultrasound 
(2) Microwave 
In 1999, Chris et al, used ultrasound in order to increase the temperature inside the tissue in a 
focused area [47]. The attenuation coefficient of ultrasound energy loss in tissue is roughly 
proportional to frequency,  thus penetration depth was controlled from less than a centimeter 
to approximately 10 cm or deeper, by varying the frequency or using focused beams, in order 
to verify the effect. Additionally, the transducer fabrication technology combined with 
wavelengths on the order of mm within this frequency range, facilitates practical applicator 
dimensions and multiple transducer configurations; thus, allowing a wide variety of shaping 
or control of the beam distributions. This includes focusing of beams using focused transducers 
or electronically phased arrays to increase localization, depth and control of heating.. As high 
intensity focused ultrasound, focuses on a small area and the control of temperature increase 
is less. In this research work, that challenge was tried to be solved. 
In 2007, Florence et al, reported analytical modelling of microwave antenna-insulated dipole 
applicators for interstitial hyperthermia [48]. In that research work, a different design of antenna 
was emphasized. The electric field radiated, power distribution and energy absorbed depend 
on the frequency of the antenna and the type of material in which the antenna is used. The 
electromagnetic field radiated in the l dielectric medium surrounding the insulated antenna 
produces energy dissipation which converts into heat. This is the fundamental logic of using 
invasive antenna for the purpose of hyperthermia. The power absorption which is also known 
as Specific Absorption Rate (SAR), is related to the temperature rise at steady state. The higher 
dissipated power appears close to the feed point.  
In 2011, Earl et al, proposed a new microwave hyperthermia approach that used time 
multiplexing of multiple beamformers [49]. Each patient-specific beamformer was designed to 
focus microwave energy at a target location while minimizing energy deposition in a normal 
tissue region  was unique to each beamformer. In this paper, a simulation of a  human brain 
was used. In this research work, with beam forming technique, the temperature was increased 
in the superficial layer. 
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In 2012, Teng Jiao has used invasive hyperthermia antenna on pork liver to increase the 
temperature [50]. The practical experiment was done for 240 second and was targeted around a 
range of 2.8 cm * 6.0 cm. In this research work, a coaxial-slot antenna was designed which 
successfully increase the temperature. Antennas were applied on a pork liver. But in this 
research work, no particular tumors were heated. 
In all the studies mentioned, there were different observations from different point of views. 
Further studies and investigations were recommended in each of these studies for combination 
of hyperthermia and radiation therapy.  
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1.7 Objective of this Research 
The purpose of this study was to identify the appropriate antenna array which can be effectively 
used on a deep-seated breast tumor to increase the temperature to more than 42.5˚C, and to 
examine the effect of a smaller cumulative radiation dose of 30 Gy.  
The motivation was to adequately heat the deep seated tumor, with lesser harm to the 
surrounding normal tissues.  
In this research work, a deep seated tumor about 5cm ~ 7 cm from the skin surface, radius of 
about 30 mm was assumed for design of different types of non-invasive and invasive antennas, 
the simulation and the experiments and analyzed heating this tumor. 
In non-invasive antennas micro-strip patch antenna and spiral antennas were designed and  
simulations were conducted using phantoms similar to human tissues.  A two micro-strip patch 
antenna array separated by a distance was applied on layers of phantoms to check the 
diffraction. During the experiment with spiral antenna array, similar phantoms were used to 
see the effect and heating penetration depth. After the experiment, with the application of 
antenna array separated by 0.5 mm, the heating depth was found to be 2 cm – 3 cm. The heating 
pattern was found to be more distributed close to skin surface and it did not penetrate deep 
seated tumor. 
In invasive antennas coaxial-slot antenna was designed and simulations were conducted using 
phantoms which were used for the non-invasive antennas. The power generation, temperature 
elevation and few other parameters, namely duration of application of antennas, the depth of 
heating penetration were compared with each other. The temperature distributions were 
measured with a breast phantom, and specific absorption rate (SAR) distributions were 
calculated using a simulation software. A coaxial-slot antenna array, consisting of two coaxial-
slot antennas, separated by a distance, and using a microwave power of 15 W increased the 
temperature of a tumor phantom, in an area of  40 mm in diameter, to over 42.5˚C in 30 min. 
The temperature as well as SAR were observed to have increased more in the tumor tissue than 
in the other types of tissues which were tested. 
 As per the initial objective of heating a deep seated tumor with lesser harm to the surrounding 
normal tissues, the coaxial-slot antenna array was found to be the most appropriate.  
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Thereafter, the radiation dose distribution of brachytherapy was examined using a treatment 
planning software. Simulations were conducted on the Computed Tomography image of an 
anonymous breast tumor patient; the tumor’s dimensions were 40 mm (length) × 30 mm 
(width). A radiation dose of 30 Gy given in 5 fractions of 6 Gy each, which is lesser than the 
conventional radiation doses used in external beam radiation therapy [xx], was applied to the 
tumor. Harm to adjacent tissues is also expected to be minimized due to lower radiation dose.  
 In conclusion, there is a possibility of local control of deep-seated small breast tumors by 
using a combination of interstitial hyperthermia applied by a coaxial-slot antenna array, 
increasing the temperature to over 42.5˚C, and radiation brachytherapy, applying a cumulative 
radiation dose of 30 Gy. 
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1.8 Outline of this Thesis 
 
This thesis consist of six chapters in total. 
Chapter one is the general introduction background of the breast cancer and its different 
treatment modalities and, the basic motivation of starting this research.. It includes the 
extensive literature survey regarding cellular effect of hyperthermia and radiation 
brachytherapy individually and in combination, and clinical trials done in different stage of the 
tumors. In this chapter, objective of the research work is mentioned. 
Chapter two describes the first part of this research work, i.e. hyperthermia, in details. The 
conventional ways of hyperthermia, different methods to implement etc., are discussed. The 
antenna design, experiments using the antenna on the phantoms, the results and the discussion 
on the results obtained are also covered in this chapter. 
Chapter three describes the second part of this research work, i.e. radiation brachytherapy in 
details. The conventional way of brachytherapy, the different methods to implement, the 
simulation results and the discussion on the results obtained are also covered in this chapter. 
Chapter four describes the steps towards optimizing the combination therapy. In order to get 
better results, the distance between the antennas were adjusted and similar experiments were 
conducted for hyperthermia and radiation therapies. The results obtained and discussion on the 
results obtained are covered in this chapter. 
Chapter five describes a general discussion on various parameters such as blood flow and how 
that varies from tumors to normal tissues.  
Chapter six describes the summary and conclusion of this research work. It discusses the 
potential next steps and future work. 
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Chapter 2  
Hyperthermia 
 
2.1 Introduction to Hyperthermia 
Microwave-hyperthermia is a method of treating cancer by heating the tumor. This distinguishes 
it from normal fever of up to 40˚C and high fever which might occur as a result of some health 
related problem such as sunstroke.  
Many methods of hyperthermia treatment are available. Hyperthermia may be local, where only a 
small restricted area of the body is heated, or it can be regional, where an entire body part may be 
heated, or whole body may be heated. Techniques that have been used for production of 
hyperthermia include conduction through the skin, recirculation of externally heated blood, heated 
intravenous fluids, ultrasound, and electromagnetic coupling modalities. These electromagnetic 
methods may be invasive or non-invasive depending on the location of the tumor. 
The objective of this artificially induced temperature rise is the treatment of tumors, directly by 
introducing irreversible biological damage or indirectly by enhancing the effects of other treatment 
regimens such as X-irradiation or chemotherapy in a synergistic way.  
Different Kinds of Hyperthermia: 
Local Hyperthermia: 
Superficial tumors can be heated by means of antennas or applicators emitting mostly microwaves 
or radio waves placed on their surfaces with a contacting medium. Several types of applicators 
have been used clinically, such as waveguide applicators, horn, spiral, current sheet, and compact 
applicators. The main components of such an invasive hyperthermia system are shown in figure 
2.1. 
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Figure 2.1 Hyperthermia by applying two antennas inside the tumor 
 
For non-invasive antennas, there is a bolus material is required to be placed between the tissue and 
the antenna. The electromagnetic coupling of the applicator to the tissue is ensured by a water 
bolus (preceding water path). Intra-tumoral temperature can be controlled by the output of the 
power generator or by positioning the applicator. The resulting SAR distribution is subject to 
strong physical curtailment resulting in a therapeutic depth of only a few centimeters and is even 
further limited in regions with an irregular surface, such as the head and neck area, the 
supraclavicular region, or the axilla.  
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Whole Body Hyperthermia: 
In whole body hyperthermia, a mild high temperature is maintained for long time. 
The effects of hyperthermia are listed below [8,52]: 
 Cell death due to high temperature and duration of application of high temperature: Due to 
high temperature cell death occurs. Temperature and duration of application of high 
temperature are also important to count the amount of cell death. 
 Variations during the cell cycles in sensitivity to hyperthermia: Normally in S phase, the 
cells are radio resistant and temperature sensitive. 
 Cell kinetics following the treatment:  
 The time required to repair the heat induced lesions 
 The effects of hypoxia and other physiological states due to increase in temperature 
Biological effects of hyperthermia: 
The effects of hyperthermia are listed below [8,52]: The cell killing property of hyperthermia 
depends on various cellular factors [53]: 
Cell cycle: Synchronized cell cultures exhibit variations in their susceptibility to heat in 
accordance to their phase in the cell cycle. In general, the highest heat sensitivity can be observed 
during the mitotic phase. Microscopic examinations of M-phase cells exposed to hyperthermia 
show damage of their mitotic apparatus leading to insufficient mitosis. S-phase cells are also 
sensitive to hyperthermia, where chromosomal damage is observed. Both S and M-phase cells 
undergo a ‘slow mode of cell death’ after hyperthermia, whereas those exposed to heat during G1-
phase are relatively heat resistant and do not show any microscopic damage. These variations 
existing between the different cell cycle phases indicate the possible diversity of molecular 
mechanisms of cell death following hyperthermia and is shown in figure 2.2. 
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Figure 2.2 Cell cycle showing the cell sensitivity to radiation during each phase 
 
 
Effects in DNA and RNA: Intracellular synthesis and polymerization of both RNA and DNA 
molecules as well as protein synthesis are decreased at temperatures over 42.5˚C. RNA and protein 
synthesis recover rapidly after hyperthermia, but DNA synthesis is inhibited for a longer period. 
Heat shock induces an aggregation of denatured proteins at the nuclear matrix. This is mainly due 
to insolubility of unfolding of heat induced protein, creating an enhancement of the nuclear protein 
concentration. Increase of the nuclear protein content due to heat consequently affects several 
molecular functions including DNA synthesis and repair when a certain thermal dose is exceeded. 
This threshold dose varies with different cell types. 
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Apoptosis Induction 
Researchers have investigated about the behavior of cells after hyperthermia and after combination 
of hyperthermia and radiation therapy. The oxygen content in the tumor cells increase due to 
hyperthermia, and oxygen as a strong radio sensitizer helps in killing the cells with lesser dose of 
radiation. 
Hyperthermia is a method of increasing temperature of tissue by an external means and it can be 
differentiated with fever. While hyperthermia has been used as a cancer therapy for over a hundred 
years, only now is equipment for physical hyperthermia has started emerging from the laboratory 
in recent years, being commercially produced, and gaining acceptance in the clinical arena.  
The properties of hyperthermia, namely making the tumor cells sensitive to radiation or even 
killing them, makes it an interesting technique which should be further investigated in combination 
with other cancer therapies. The amount of cells killed depends on the thermal dose, which is a 
function of temperature and time. Hyperthermia is practiced for more than 100 years above. 
However, due to the complexity of heat induced changes, the accurate experimental set-up and 
optimum thermal dose is still under investigation. Here, several cellular effectors of hyperthermia 
are being described. 
Methods to increase temperatures 
To reach temperatures clearly above the systemic temperature of 37·5°C in a defined target volume 
is a technical challenge and still under development. The temperature increase is induced by 
applying a power-density specific absorption rate (SAR; measured in W/kg). Human basal 
metabolic rate (basal metabolism) is above 1 W/kg. Perfusion counteracts the temperature rise. 
Perfusion rates in tumors are around 5–15 mL per 100 g per min, but they vary widely. To reach 
therapeutic temperatures of about 42°C at least in some parts of such tumors necessitates power 
density of about 20–40 W/kg at the target region[5]. 
At present, the optimum temperature distribution for clinical purposes is unknown. Temperature 
distributions achieved to date have limited absolute values and homogeneity (minimum 
temperatures typically lie between 39·5°C and 40·5°C), mainly because of physical and 
physiological characteristics such as electrical tissue boundaries, local perfusion variations, and 
perfusion regulations. Only about 50% of deeply located tumors reach at least 42°C at one 
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particular measurement point. Clinical studies have shown that uncritical adoption of preclinical 
results into clinical guidelines for tumor temperatures is not justified. Nevertheless, many phase II 
clinical studies have shown associations between tumor response and characteristics of 
temperature distribution (minimum temperature or minimum thermal dose in the tumor area). 
Even though the tumor temperatures that have to be reached for clinical efficacy are still unclear, 
we should achieve temperature distributions as high and homogeneous as possible. Technological 
potential for in vivo monitoring and control of temperature distribution has not yet been intensively 
scrutinized, at least for the regional hyperthermia approach. 
 
 
2.2 Modalities of Hyperthermia 
Hyperthermia can be achieved by different modalities using different waves. Following are some 
of them: 
(i) Ultrasound:  High intensity focused ultrasound can be used to achieve high temperature 
regions inside a patient without requiring any invasive interaction. A multitude of 
ultrasound transducers, i.e. up to two thousand, positioned in a phased array is used to 
produce a small, well defined pressure focus. As the pressure oscillates, microscopic 
movement is produced that translates heat due to friction. The heat focus can be used 
to coagulate tissue or to temporarily increase drug intake in certain cells by breaching 
the blood brain barrier. Sometimes MR guidance is used to safely steer and monitor the 
ablation process. 
(ii) Microwave: Microwave ablation is used treat various kinds of tumors. Invasive or non-
invasive antennas are used to increase the temperature. In various cases, one or multiple 
ablation antennas are inserted in a minimally invasive manner into the treatment region. 
The invasive catheters are inserted in a minimally invasive manner into the treatment 
region. Non-invasive antennas are able to increase the temperature of the superficial 
tumors lying within 2 cm under the skin layer. 
In the experiments, hyperthermia was applied using the frequency 2.45 GHz as it comes 
under Industrial, Scientific, and Medical (ISM) band in Japan, the U.S., and some other 
countries. 
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2.3 Antenna design 
 There are two types of microwave antennas are used for hyperthermia:  
(i) Non-invasive: Non-invasive antennas are those which are applied from outside of the 
body. Normally it is places in the skin just above the skin or focusing antennas effects 
towards a particular tumor. 
During this research work, two types of non-invasive antennas were designed: 
(a) Micro-strip patch antenna 
(b) Spiral Antenna 
(ii) Invasive: Invasive antennas are those minimally invasive antennas, light weight and 
easy to use. 
In this research work, one type of invasive antenna was designed: 
(a) Coaxial-slot antenna 
 
Non-invasive micro-strip patch antenna 
Micro-strip patch antenna is a common type of non-invasive antenna. It has a number of 
advantages over other antennas, such as: it is light weight, inexpensive and easy to make conformal 
structures. As it is a non-invasive antenna, it generates the far field when used. 
Figure 2.2 shows the basic structure of a micro-strip patch antenna: a flat plate over a ground plane. 
This antenna is often built of printed circuit board material and the substrate makes up the patch 
antenna’s dielectric. Antenna parameter diameters depends on the frequency on which it is 
operated.  
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Figure 2.2 Basic structure of micro-strip patch antenna 
 
A half wave long patch operates in what we call the fundamental mode: the electric field is zero at 
the center of the patch, maximum on two sides, and minimum on the other two sides. These minima 
and maxima continuously change side like the phase of the RF signal. 
The electric field does not stop abruptly near the patch’s edges like it would in a cavity: the field 
extends beyond the outer periphery. These field extensions are known as fringing field and cause 
the patch to radiate. Figure 2.3 explains the radiating sides and non-radiating sides. 
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Figure 2.3 Working principle of micro-strip patch antenna 
 
The distance to which the radiation pattern can be obtained is given by the equation [54]: 
 
 
Where, W: Width of the antenna 
   λ: Wavelength 
As the frequency is fixed for this research work, wavelength is also a fixed amount. More the width 
of the antenna, greater is the distance covered by the antenna. As the antenna here is applicable on 
the human breast, the antenna parameter cannot be too big. 
Table 2.1 shows the dimension of parameters of the micro-strip patch antenna. 
 
 
 
Distance of far field =  
2𝑊2
𝜆
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Table 2.1 Dimension of micro-strip patch antenna 
Description 
 
Value 
Height  
 
1.54 (in mm) 
Width 
 
48.6 (in mm) 
Length  
 
40.76 (in mm) 
Small thickness 
 
0.02 (in mm) 
Dielectric material 
 
2.17 
 
Experiments with Micro-strip patch antenna 
At first, layers of different tissue phantom are made. The dielectric properties of the phantoms 
used are described in table 1.1.  
The micro-strip patch antenna was applied on the layers of tissue for some time to increase the 
temperature. Infra-red images were taken after heating the layers of phantoms. To get a better 
heating, two antennas were applied. 
Figure 2.4 (a) shows the different layers of phantoms used. Figure 2.4 (b) and (c) shows the 
application of one micro-strip patch antenna and two micro-strip patch antennas.  
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(a) 
 
 
(b) 
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(c) 
Figure 2.4 (a) Layers of different phantoms on which the antenna was applied; (b) Application of 
one micro-strip patch antenna; (c) Application of two micro-strip patch antennas 
 
Further it was applied on a more realistic breast phantom. The temperature rise was recorded. 
Figure 2.5 shows the different layers of tissue phantoms used to make a realistic breast structure 
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Figure 2.5 Different layers of phantoms 
 
Non-invasive spiral antenna 
If the arms of a dipole antenna is wrapped, it becomes a spiral antenna. Spiral antennas are also 
known as frequency independent antennas. These antennas are characterized as having a large 
bandwidth. Thus, these antennas are efficient in a wider range of frequency. Spiral antennas are 
usually polarized. The spiral antennas radiation pattern typically has a peak radiation direction 
perpendicular to the plane of the spiral.  
Figure 2 shows the basic structure of the spiral antenna.  
In this research work, the spiral antennas were used on the different layers of phantoms used which 
is described in table 1.1. Spiral antenna was applied on layers of different tissue phantoms to get 
the temperature rise. 
The specifications of the spiral antenna are given in table 2.2. 
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Table 2.2 Specifications of Spiral antenna 
Angle maintained 
 
90˚ 
Number of arms 
 
3 
Width of each arm 
 
2 mm 
 
Figure 2.6 (a) shows the basic structure of the spiral antenna and (b) shows the dimension of the 
spiral antenna respectively. 
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(a) 
 
(b) 
Figure 2.6 (a) Basic structure of spiral antenna; (b) Dimension of the spiral antenna 
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Experiments with Spiral antenna 
The spiral antennas were applied on the layers of tissue for some time to increase the temperature. 
Infra-red images were taken after heating the layers of phantoms. Figure 2.7 shows the application 
of spiral antenna on a breast phantom of diameter 7 cm as shown in figure 2.5. 
 
 
Figure 2.7 Application of spiral antenna on a breast phantom 
Infra-red images were recorded using an infra-red camera. 
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Invasive coaxial-slot antenna 
In this research work, coaxial-slot antenna is a type of invasive antenna which was designed and 
applied to get a desired results for tumor phantoms. 
Figure 2.8 shows the basic structure of the coaxial-slot antenna. 
 
 
Figure 2.8 Basic structure of coaxial-slot antenna 
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In the experiments conducted, interstitial hyperthermia was applied on breast tumor phantoms. 
A coaxial-slot antenna was used to localize the heating effect. Advantage of using coaxial-slot 
antenna is the ability to heat deep seated tumors, with minimum diffraction.  
Antenna parameters and the spacing between the slots for coaxial-slot antennas were calculated 
for the frequency of 2.45 GHz. The antenna was designed particularly for breast tumor.  The 
coaxial-slot antenna is shown in Figure 7. The parameters used for designing the antenna are listed 
in Table 2.3.  
Two coaxial-slot antennas, separated by 5 mm, were used in the array in order to get the 
maximum heating effect in the intermediate zone between the two antennas. 
Table 2.3. Dimensions of coaxial-slot antenna 
 
Parameters Value 
Diameter of antenna   1.19 mm 
External diameter of the catheter    1.79 mm 
Thickness of the catheter   0.30 mm 
Distance from the tip to the center of the slot close to the feeding point 20.00 mm 
Distance from the tip to the center of the slot close to the tip 10.00 mm 
Width of the slot  1.00 mm   
Relative permittivity of the catheter  2.6    
  
In order to see the exact temperature elevation inside the phantoms, the phantoms were cut into 
halves and after the application of antennas, one half was taken away. Infra-red camera was used 
to record images thereafter. Fiber optic sensors were used during the experiments to record the 
temperature rise. 
Figure 2.9 shows the steps followed during the experiments. 
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Figure 2.9 Steps followed during the experiments 
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2.4 Results 
2.4.1 SAR Calculation 
The basic concept of SAR is that a tissue exposed to the electromagnetic radio waves absorbs 
power from these waves, and this power gets distributed throughout the tissue [54].   The equation 
for SAR is shown in Equation (1). 
 
|SAR| = σ
|E|2
ρ
                                                                                                   (2)  
Where σ : conductivity of the tissue (S/m), 
        ρ : density of the tissue (kg/m3),  
        |E|: electric field (V/m).  
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SAR Distribution of Micro-strip Patch Antenna 
SAR distribution of the micro-strip patch antenna was calculated. Figure 2.10 shows the SAR 
distribution of the micro-strip patch antenna. 
 
 
 
Figure 2.10 SAR distribution of micro-strip patch antenna in breast tissue phantom 
 
 The electromagnetic field around the antenna was calculated using the Finite Integration 
Technique (FIT) [55].  For FIT calculations, a mesh structure of the antenna was created and 
boundary conditions were applied. Figure 2.11 shows the port created inside the micro-strip patch 
antenna for SAR distribution and temperature distribution. 
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Figure 2.11 Finite Integration Technique Calculation inside Phantom 
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SAR Distribution of Spiral Antenna 
SAR distribution was measured in different phantoms using spiral antenna array. Figure 2.12 
shows the SAR distribution of spiral antenna inside the breast tissue. 
 
 
Figure 2.12 SAR Distribution of Spiral Antenna array in breast tissue 
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SAR Distribution of Coaxial-slot Antenna 
As coaxial-slot antenna is an invasive type of antenna and it can be inserted exactly the desired 
location.  
During this research work, deep seated tumors were targeted by coaxial-slot antenna array and it 
was inserted 7cm inside the phantom. Figure 2.13 shows the SAR distribution of coaxial-slot 
antenna array inside the tumor phantom. 
 
Figure 2.13 SAR distribution of coaxial-slot antenna array in tumor phantom 
 
The cross-sectional view of antenna and catheter, and boundary conditions are shown in Figure 
2.14. The length of antenna used was 140 mm and the depth of penetration of this antenna in the 
phantom was 70 mm. The length of the boundary was considered to be 180 mm.  
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Figure 2.14 Cross sectional view of Coaxial-slot antenna 
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Temperature Calculation 
Temperature calculation for all the antennas were done on the tumor phantom. The temperature 
calculation  
Table 2.4 shows the comparative study between the temperature increases by all antennas used in 
this study. 
Table 2.4 Temperature obtained by different antennas  
Name of the antenna Microwave Power Duration Temperature 
Micro-strip patch antenna 25 Watt 30 Minutes 9˚C 
Spiral antenna 15 Watt 30 Minutes 10.5˚C 
Coaxial-slot antenna 15 Watt 30 Minutes 12˚C 
 
The increase in temperature [57,58] due to application of the antenna was calculated using Penne’s 
bio-heat transfer equation, shown in Equation (2). Body temperature was considered to be 37˚C. 
                      (ρ cp)t
∂Tt
∂t
= ∇ (kt ∇Tt) + qp + qm + 𝜌 𝑆𝐴𝑅                                         (3)    
where ρ: tissue density 
   cp : tissue-specific heat  
   Tt,: tissue temperature 
    kt: tissue thermal conductivity 
    qp: heat transfer from blood to tissue 
   qm: uniform rate of metabolic heat generation in the tissue layer per unit volume 
      SAR: Specific Absorption Rate 
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For the calculations in this research work, tissue density (ρ) was considered to be 916 kg/m3, 
tissue specific heat (cp) to be 2,300 J/Kg·K, tissue temperature (Tt) to be 37˚C, tissue thermal 
conductivity (kt) to be 0.33 W/m·K, and uniform rate of metabolic heat generation (qm) to be 4.7 
X 103 Watt/m3. The heat transfer from blood to tissue (qp) was disregarded—the temperature of 
blood and tissue were assumed to be the same in the experiments. The SAR varies; the value of 
SAR decreases when the distance from the catheters increases, which is shown later in this chapter. 
Temperature at the surface of the phantom was calculated using Equation (3). This equation gives 
the heat lost from the surface of a phantom due to lower ambient temperature. 
  k
∂T
∂n
= −h (T − Ta)                                                                                       (4) 
where k: thermal conductivity, 
∂T/ ∂n: rate of change in temperature to  unit vector normal to the surface of the phantom,             
h: convective heat transfer coefficient from the surface of the phantom to the outside air 
(W/m2 K),  
T: temperature, 
Ta: ambient temperature (˚C).  
In the experiments, h was considered to be 10.5 W/m2 K and Ta to be 27˚C. 
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Use of Bolus Material for non-invasive antenna 
Bolus material is used for getting resonance at desired frequency and also used for avoiding skin 
ablation.  
During this research work, different types of bolus materials were used such as normal water, 
distilled water and saline water. Distilled water gave the best result among these. 
Figure 2.15 shows the difference between the temperature of the phantom using bolus material and 
not using bolus material. 
 
Figure 2.15 Difference between the temperature of the surface using and not using bolus material 
 
In the experiments, the temperatures were measured using a fiber optic temperature sensor inserted 
in the tumor phantom. Infrared images were also recorded using an infrared camera. 
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Figure 2.16 (a) shows the experiment set up with the coaxial-slot antenna array applied on a 
phantom and Figure 2.16 (b) shows the infrared images after application of the antenna array. Due 
to different dielectric properties, the rate of increase in temperature is different for different types 
of tissue phantoms.  
 
Figure 2.16 (a) Coaxial-slot antenna array applied on a phantom; (b) Infrared images of different 
types of phantoms after applying coaxial-slot antenna array. 
 
 
 
 
 
 
20 mm
Infrared images
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Figure 2.17 shows the increase of temperature of different phantoms over the time. This difference 
was obtained due to different dielectric properties of the tissues. 
 
Figure 2.17 Temperature rise in different homogenous phantoms over 30 minutes of time. 
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Difference between the temperature obtained in experiments and simulation 
In both experiments and simulations, the dielectric constants of the phantoms were maintained 
the same as shown in chapter 1, Table I.  However, there were differences between the results of 
practical experiments and those of simulations. The increase in temperature was calculated in 
simulation as well as in phantoms. Figure 2.18 shows the difference between the temperatures 
achieved in experiments and simulations. With the same microwave power, the difference in 
temperature was found to be around 6˚C to 9˚C. This difference is because of the different 
boundary conditions in experiments and simulations. 
 
Figure 2.18. Temperature difference between the experimental results and simulation results 
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Temperature dependency on RF Power 
 
Radio Frequency (RF) power and time are two interdependent factors that can be adjusted to 
increase the temperature in hyperthermia. The experiments were conducted keeping the time 
constant at 30 minutes.  Figure 2.19 shows the dependency of temperature on RF power keeping 
the time constant at 30 minutes. This result is from the experiment conducted on homogenous fibro 
glandular tissue phantom. 
 
Figure 2.19. Temperature dependency on microwave power 
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2.5 Discussion 
Two major categories of antenna are available in hyperthermia to heat the tumor: non-invasive 
and invasive. In the early phases of this research work, non-invasive antennas, namely, micro strip 
patch antenna and spiral antenna, were designed and tested on different types of phantom. The 
heating and depth of penetration were better in the case of spiral antenna as compared to micro-
strip patch antenna. While both the non-invasive antennas gave good results for heating of a 
superficial tumor few centimeters beneath the skin, there was limited or no impact on deep-seated 
tumors. There was also a possibility of ablation of skin and other tissues adjacent to the tumor. 
Table 2.5 shows the comparative study between the non-invasive antennas and invasive 
antennas. 
Table 2.5 Comparative study between the non-invasive antennas and invasive antennas 
Factors Non-invasive antenna Invasive antenna 
Depth of tumor 
 
 
Cannot heat a deep-seated tumor     
         
Possible to heat a tumor 
located at any depth 
Effect on adjacent 
tissue 
Temperature increases in adjacent 
tissues– higher chances of skin 
ablation 
Less harm on adjacent tissues 
Bolus material 
 
 
Needed Not needed 
 
As mentioned in the above table, non-invasive antennas were used for heating the superficial 
tumors which were located around 2-3 cm below the skin layer. During the experiments, non-
invasive antennas were used to add their effects and then focus on a tumor which is located deeper 
than 3cm, but it was not effective due to high diffraction from human tissue.  
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As this research work was focused on deep seated tumors, coaxial-slot antenna was chosen for 
further analysis. For coaxial-slot antenna the risk of effects on normal tissue due to high 
temperature such as skin ablation, can be avoided. Another advantage of using coaxial-slot antenna 
is, there is no requirement of using bolus material for coaxial-slot antenna.  
Blood flow inside the breast is an important factor which impacts the temperature [59]. There 
may be some changes in the duration required to reach the desired temperature once blood flow is 
considered. While blood flow was not taken into account in the experiments conducted on the 
phantoms as part of this research work, it was considered in the simulations. As the blood flow is 
understood to significantly impact temperature, the effects of blood flow—both in the tumor and 
normal tissue—is an important field to study further. 
At this point in time, despite a strong rationale for combining interstitial hyperthermia and 
radiation brachytherapy, interstitial hyperthermia is still an out of routine clinical practice. One of 
the reasons for hyperthermia’s slow adoption is understood to be a need for high quality equipment, 
which in turn have to be operated by well-trained personnel. Based on the results from the studies 
hitherto and from this research work, we assert the need for further investigation on the 
effectiveness of combination therapy using interstitial hyperthermia and brachytherapy on deep-
seated breast tumors. 
 
 
 
 
 
 
55 
 
Chapter 3 
Radiation Brachytherapy 
 
3.1 Introduction to Radiation Brachytherapy 
Brachytherapy is a method of delivering radiation to tumors by placing radioactive sources either 
within or immediately adjacent to tumor tissue. Because the radiation source is very close to the 
tumor,  it can affect the tumor  while minimally affecting normal tissue surrounding the tumor. 
Brachytherapy can be provided using Low Dose Rate (LDR) or High Dose rate (HDR) techniques, 
depending on the length of time the radioactive sources remain in place. 
 
Radiation Effects on Cancerous Cells: 
 Years of experiments have shown the impact on in cells due to radiation exposure [xx].  
There are two commonly known effects: 
(i) Direct Effect: If an X-ray or radiation interacts with the DNA , this is considered a 
direct effect. The direct effect of radiation causes more damage to the DNA. 
(ii) Indirect Effect: When X-rays enter a cell, they are much more likely to hit the water 
molecules and ionize these water molecules which in return produces ions and free 
radicals. These ions and free radicals  in turn bond with the DNA molecules and change 
its structure.  
 
 
Brachytherapy can be provided alone or in combination with other therapies such as surgery, 
external beam radiation therapy and chemotherapy. 
Depending on the type of the cancers, and the treatment plan, course of brachytherapy can be 
completed in lesser time than that required for other radiotherapy techniques. This can help reduce 
the opportunities for surviving cancer cells to divide and grow in the intervals between 
radiotherapy doses. With brachytherapy, patients typically make fewer visits to the radiotherapy 
clinic compared with external beam radiation therapy, and the treatment is often performed on an 
outpatient basis. This makes treatment accessible and convenient for many patients. Brachytherapy 
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is also associated with a low risk of serious adverse side effects. These features of brachytherapy 
mean that most patients are able to tolerate the procedure very well. 
Breast brachytherapy is in that matter is a promising alternative to surgery or external beam 
radiation therapy, in terms of improved patient cure, organ preservation, and cost of efficiency of 
the treatment. 
 
Breast Brachytherapy 
Radiation therapy is the standard of care for women who have undergone breast lumpectomy or 
mastectomy surgery,  and it is an integral component of breast conserving therapy [55]. 
Brachytherapy can be used after surgery, before chemotherapy or  in the case of advanced forms 
of the disease [55]. Brachytherapy to treat breast cancer is usually performed with high dose rate 
using temporary implants. Post-surgery, breast brachytherapy can also be used as a ‘boost’ 
following the irradiation of the whole breast using external beam radiation therapy [61,62]. More 
recently brachytherapy alone is applied in a technique called APBI (accelerated partial breast 
irradiation), which involves delivery of radiation to only the immediate region surrounding the  
tumor [61-63]. 
The main benefit of breast brachytherapy compared to external beam radiation therapy is that a 
high dose of radiation can be precisely applied to the tumor while minimizing radiation exposure 
to the healthy breast tissues and underlying structures such as ribs and lungs [60]. Accelerated partial 
breast irradiation can typically be completed over the course of a week [63]. The option of 
brachytherapy may be particularly important in ensuring that working women, the elderly or the 
women without an easy access to a treatment center, are able to benefit from breast-conserving 
therapy due to the short treatment course as compared with external beam radiation therapy [59]. 
Brachytherapy has demonstrated excellent local control of breast cancer at a follow-up of up to 6 
years post treatment [60, 65, 66]. A study is underway to compare patient outcomes of APBI in 
comparison to external beam radiation therapy at a follow-up of up to 10 years after the treatment 
[67]. 
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Breast Brachytherapy as a Boost: This section describe the combination of surgery and 
brachytherapy as a radiation therapy for treating breast tumors. The goal of irradiation is to 
minimize the risk of a local relapse in the treated breast, especially in the area of a tumorThere are 
many methods of increasing the dose to the tumor area [52, 68-69]. The best approach is chosen 
depending on clinical and morphological criteria, patient’s will and institutional resources and 
protocols. Modern interstitial multi-catheter high-dose rate (HDR) brachytherapy offers local and 
accurate irradiation of the target tumor. Randomized “boost vs. no boost” trials revealed that there 
is an evident advantage from administering an additional dose to the tumor area. A boost reduces 
the local recurrence rates [72-74]. Polgár et al. also summarized the results of many different high 
dose rate brachytherapy series worldwide, in which , a 5-year local recurrence rate of 0-9% (mean 
5.5%) was achieved in 1776 patients [52]. Brachytherapy is appropriate to deliver an additional 
conformal boost dose to the surgical area plus margin following standard whole breast radiation 
therapy. Choice of brachytherapy would be dependent on the size, shape, and location of the 
lumpectomy cavity in relation to the size and shape of the breast [57]. While an external electron 
beam boost usually includes the skin and subcutaneous vessels, the interstitial implant represents 
a more local treatment technique, which offers the advantage of lower rates of side effects, in 
particular of skin telangiectasia and skin fibrosis [75-77]. Clinical trials showed an increase in local 
control and an increase in survival among patients with boost as compared to patients with no 
boost [74, 78-80]. In the European Organization for Research and Treatment of Cancer (EORTC), a 
“boost versus no boost” randomized trial , 2661 patients enrolled in the boost arm were analyzed. 
All the patients received 50 Gy whole breast radiation therapy and a boost dose of 16 Gy to the 
primary tumor area after microscopically complete tumorectomy. 63% of the patients received a 
boost dose with electrons, 28% with photon beams, and 9% with interstitial brachytherapy. At 5 
years of follow-up, local recurrences were seen in 4.8% of patients who received an electron boost, 
in 4% of cases with a photon boost received, and in 2.5% of patients who underwent brachytherapy 
[81-82]. From the above result obtained from tumors treated by different modalities, brachytherapy 
gave a lesser recurrence rate of tumor as it is given locally and more targeted to the tumor.  
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3.2 Conventional Brachytherapy 
 
There are few methods that are used to deliver breast brachytherapy:  
(1) Interstitial breast brachytherapy- Brachytherapy using interstitial applicators can be 
delivered in two ways. Perioperative brachytherapy involves the usage of flexible 
applicators during surgery at the place of the tumor. In this method, brachytherapy is 
applied during the breast conserving surgery. The advantage of the perioperative technique 
is the need for only one general anesthesia (implantation of the applicators takes place 
during surgery), resulting in a reduction of overall treatment time, and the ability to 
precisely determine the location of the tumor visually during the surgery. During a 
lumpectomy/ mastectomy the surgeon attaches surgical clips to determine the tumor 
boundary, later these surgical clips are helpful in treatment planning. Insertion of the 
applicators requires precision, experience and knowledge in the field of radiation. The 
irradiated area is limited to the surgical area with a margin of 1-1.5 cm. 
In another way, applicators are often implanted after the healing of the surgical scar and 
after receiving the final histo-pathological diagnosis in 2-4 weeks after the surgery. The 
radiation oncologist inserts applicators after visualization of the tumor area (the location of 
surgical clips) using X-ray and ultrasound. After determining the shape and position of the 
tumor area, a correct template is selected; the number of tumors, the distance between the 
applicators is proposed. The number of implanted applicators has to be determined 
individually, depending on the breast size, location of the tumor area, and type of surgery. 
Usually there are from seven to over a dozen applicators.  
(2) Intra cavitary breast brachytherapy- This technique was intended to reduce the 
technical difficulties associated with external beam radiation therapy treatment planning 
and application of many interstitial applicators [85-86]. The balloon applicator consists of a 
silicone balloon catheter containing a channel for filling the balloon and 1 to 8 channels to 
introduce radioisotope. Strut adjusted volume implant applicator does not include a balloon 
but only applicators to adapt to the shape of the box. Balloon technique is in principle 
applicable in accelerated partial breast irradiation with resignation of whole breast radiation 
therapy after surgery. High-dose-rate sources are used in this technique. Balloon 
applicators may be placed near the tumor during the breast conserving surgery (rarely) or 
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2-4 weeks after surgery with the help of ultrasound. Previously published results suggest a 
satisfactory treatment outcome (as measured by the percentage of local failure), and good 
cosmetic results (80% to 93% of patients) [87-90]. The results of Phase III Trial (NSABP B-
39/RTOG 0413) conducted by the National Surgical Adjuvant Breast and Bowel Project 
(NSABP) and the Radiation Therapy Oncology Group (RTOG) had shown a comparative 
study between different treatment methods. Whole breast radiation therapy, Accelerated 
partial breast irradiation with MammoSite or multi catheter interstitial BT 3D EBRT in 
stage 0, I and II of breast cancer [91]. Balloon brachytherapy was developed as an alternative 
to interstitial brachytherapy. Interstitial brachytherapy requires the experience in setting up 
many interstitial applicators, while using balloon brachytherapy is simpler in application. 
Cosmetic results after balloon brachytherapy techniques seem to be very satisfactory. A 
high rate of satisfactory or excellent results is worth noting. To achieve such results the 
proper selection of patients (large breasts, the central location of the primary tumor) is 
important. 
The balloon applicator consists of a silicone balloon with a catheter to fill the balloon with 
fluid and 1 to 8 channels where a radioactive source is placed. For greater precision in most 
centers using this method, the balloon is fixed in the operating room under ultrasonography. 
Then, the applicator is fluid-filled to a volume strictly adhering to the walls of the tumor 
boundary. Then a cross-section CT is made in order to prepare a treatment plan. Clinical 
target volume (CTV) includes the volume of the balloon with a margin of 1 cm. Critical 
organs include the skin and lungs. In this technique HDR sources are used. 
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Literature Survey on Clinical Studies for Radiotherapy 
Various reports have shown almost equivalent results between short and standard radiotherapy 
schedules [76-79]. In a randomized trial conducted in Canada, Whelan et al [92] reported equivalent 
results (regarding local-regional tumor control, survival, and post-radiation effects) between the 
standard fractionation schedule of 50 Gy in 25 fractions of 2 Gy each, and a hypo fractionated 
scheme of 42.5 Gy in 16 fractions of 2.6 Gy each over 22 days for women with early stage breast 
cancer. This study has been updated recently and, most importantly, results have not changed after 
a 10-year follow-up [93]. However, the potential limitations of this study are as follows: The trial 
was restricted to women who had node negative, invasive breast cancer with clear margins of 
excision after lumpectomy; women with large breasts were not included; few women received 
adjuvant chemotherapy and we should bear in mind that those patients can be at a higher risk for 
acute and late post-radiation effects; boost irradiation was not used, as by the time the study was 
initiated, the efficacy of boost irradiation had not been demonstrated [93] and was later shown in 
studies conducted in Europe[73-74]. However, boost irradiation was used in Standardization of 
Breast Radiotherapy trials, and adjuvant chemotherapy was used more widely than in this trial. In 
addition, a broader spectrum of tumors and patients (node-positive, larger tumors, no limitation of 
breast size) were included, but no differences have been noted in tumor control and side-effects 
between standard and another treatment in those trials so far. 
Another short RT schedule, 40 Gy in 15 fractions of 2.6 Gy each, has been used traditionally at 
Christie Hospital in Manchester, UK; the reported results of 2,159 treated patients are comparable 
to those reported from other treatment centers [94-95]. This schedule is now becoming the “standard” 
in the UK, especially after the publication of the START trials. The START A trial randomized 
2236 patients from 17 treatment centers across the UK and reported that 41.6 Gy in13 fractions or 
39 Gy in13 fractions are similar to 50 Gy in 25 fractions in terms of local-regional tumor control 
and late normal tissue effects, same as post-radiation effects. The initial trial [96] showed that after 
a median follow-up of 5.1 years, the rate of local-regional tumor relapse was 3.6% after 50 Gy, 
3.5% after 41.6 Gy, and 5.2% after 39 Gy. The estimated absolute differences in 5-year local-
regional tumor relapse rates compared with after 50 Gy were 0.2% after 41.6 Gy and 0.9% after 
39 Gy. Clinical assessments suggested lower rates of late adverse effects after cumulative effect 
of 39 Gy than cumulative effect of 50 Gy. Lesser radiation dose gave lesser late adverse effects.  
The results have shown that breast cancer and late reacting normal tissues respond similarly to 
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change in radiotherapy fraction size. 41.6 Gy in 13 fractions was similar to the control regimen of 
50 Gy in 25 fractions in terms of local-regional tumor control and late normal tissue effects. The 
START B trial [97] randomized 2215 patients from 23 centers across the UK and reported that a 
radiotherapy schedule of 40 Gyin15 fractions offers equivalent results to the standard schedule of 
50 Gy in 25 fractions. After a median follow-up of 6.0 years, the rate of local-regional tumor 
relapse at 5 years was 2.2% in the 40 Gy group and 3.3% in the 50 Gy group. Clinical assessments 
indicated lower rates of late adverse effects after 40 Gy than after 50 Gy. Although the START 
trials had a relatively limited follow-up time and differences in their design (inclusion criteria) 
compared with the Canadian trial, their results were similar. 
Other non-randomized studies have also reported similar results, such as fujii et al [98] reported 
acceptable results in terms of local control and toxicity a short fractionation schedule of 42.5-47.8 
Gy in 16-20 fractions.  
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3.3 Proposed Method 
 
In this research work, a combination of hyperthermia and brachytherapy is proposed as an 
effective treatment for deep-seated breast tumors of size 30mm~40mm. In the conventional way 
of treating breast tumor, a combination of surgery, radiation therapy and chemotherapy is 
commonly tried. In such cases, normal cells in the breast also get irradiated by a high dose of 
radiation. As a result, chances of side-effects are high.  
Normally brachytherapy is applied on a localized area by inserting a radioactive source in a 
catheter [62]. This study focuses on method of sequentially applying brachytherapy after applying 
hyperthermia. In this study, a method of introducing the radioisotopes in the same catheters as 
those that were used in hyperthermia is proposed. After the application of hyperthermia, the 
coaxial-slot antennas will be removed whereas the catheters will be maintained in the same place. 
The radioactive sources will then be introduced in the same catheters as shown in figure 3.1. 
Iridium-192 is assumed to be the radioactive source.  
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Figure 3.1 Combination of two methods: hyperthermia and radiation dose distribution for breast 
tumor. 
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3.4  Calculation of Radiation Dose 
A treatment planning simulation software based on the Monte Carlo method was used to 
observe the effect of radiation doses applied using brachytherapy. A CT image of an 
anonymous patient’s breast tumor, which had dimensions of 40 mm x 30 mm, was used to 
conduct the simulations. Firstly, a Region of Interest (ROI) was drawn. Then a radiation 
treatment planning was conducted according to the spread of the tumor. In the experiments for 
hyperthermia, which were conducted using a coaxial-slot antenna array, the maximum increase 
in temperature was observed in an area of 30 mm around the catheters. In the simulations 
conducted for radiation brachytherapy, the same area of 30 mm around the catheters was 
targeted. The effect of radiation dose outside this target area was also observed. 
In the conventional external beam radiation therapy, generally a high cumulative radiation dose 
of 50 Gy to 60 Gy is applied [99]. There is a possibility that the radiation dose can be reduced 
if applied in combination with hyperthermia. Further investigations are required to accurately 
measure the reduction possible.  
 Figure 3.2 illustrates the concept of applying interstitial brachytherapy in combination with 
invasive hyperthermia on a breast tumor. The tumor is shown in black color. The maximum 
effect of the combination, an increase in temperature to over 42.5˚C and a cumulative radiation 
dose of 30 Gy, is shown using dark color. Lighter shades are used to illustrate that as the 
distance from the catheter increases, the effect of the combination decreases.   
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Figure 3.2 Concept of combining temperature and radiation dose distribution. 
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Figure 3.3 shows the result of a simulation of radiation distribution after applying radiation 
sources using two catheters. The effects of various radiation doses were observed using 
simulations conducted for a breast tumor having the dimensions 40 mm x 30 mm. A cumulative 
radiation dose of 30 Gy was determined to be effective, with minimal harm to the adjacent tissues, 
for such a tumor. 
 
 
Figure 3.3 Radiation distribution after applying radioactive source. 
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 Moreover, while in the immediate vicinity of the catheters, a cumulative radiation dose of 30 Gy 
was observed, as the distance from the catheter increased, the effect of radiation dose was reduced. 
In the region inside the inner circle colored in yellow—up to a distance of 30 mm from the 
catheter—a cumulative radiation dose of 30 Gy was observed; in the region between the inner 
circle colored in yellow and the outer circle colored in white—at a distance between 30mm and 50 
mm from the catheter—a cumulative radiation dose between 30 Gy and 10 Gy was observed; in 
the region over a distance of 50 mm from the catheter, a cumulative radiation dose of less than 10 
Gy was observed. 
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3.5 Discussion 
The research conducted for part was using Oncentra Workstation which is a treatment planning 
simulation software based on Monte Carlo Simulation, in The University of Tokyo Hospital. 
To accurately measure the positive effects of the proposed method , further deeper study and 
experiments are needed. 
In conventional treatment of breast tumor, usually a combination of breast conserving surgery 
and external beam radiation therapy is used. A high radiation dose is given post-surgery and it 
covers a wider region. This method increases the impact on the normal tissues adjacent to the 
tumor. 
 Harry et al. (2007) had shown the results of a cumulative radiation dose of 50 Gy applied by 
external beam radiation therapy, with and without a radiation boost of 16 Gy, on stage I and II 
breast cancer in 5,318 patients [73]. The conclusion after a median follow up period of 10.8 
years was that a boost of 16 Gy to the standard 50 Gy breast radiation therapy significantly 
lowers the risk of local recurrence rates. 
In this research work, while the effect of a lower cumulative radiation dose of 30 Gy applied 
by brachytherapy was simulated using a CT image of an anonymous breast cancer patient, 
further investigations are needed to establish the effectiveness of this combination treatment. 
In 1981, Miller et al had reported an extensive study on results of application of different 
modalities for cancer treatment [100]. This report gave a summary of the conclusions and 
recommendations resulting from combinations of different modalities used for treating tumors. 
This study was initiated by the World Health Organization. For the combined treatment 
modality, the study suggested to clearly establish the time relationship of the different forms 
of therapies i.e., whether given concurrently, sequentially, during the primary therapy, 
maintenance, or any other way.  
As in the previous chapter it was mentioned that invasive antenna was selected for further 
analysis and brachytherapy was a selection for delivering radiation due to the same purpose. 
Brachytherapy also has the advantage of delivering higher doses of radiation therapy with less 
dose to the surrounding normal tissues, thus minimizing toxicity in patients. Early studies have 
revealed  that survival is proportional to the dose of radiation delivered.  
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However brachytherapy may not be sufficient to combat all types of breast tumors. Tumor 
cells have their own strategy to resist radiation. Few of the strategies are: 
1. Tumor Burden: In some cases, the tumor mass is huge. Due to inhomogeneity in blood 
flow and oxygen supply in that mass, radiation alone cannot uniformly destroy the full 
mass of the tumor. 
2. Tumor Microenvironment: Hypoxia, i.e. lack of oxygen supply inside the tumor makes the 
tumor radio resistant. 
3. Inherent or acquired treatment resistance: Due to pre irradiation or inherent genetic 
structure the tumor tissue may be radiation resistant. 
4. Repopulation during the treatment: Mostly radiation treatment is fractionated in many 
doses and there is a time gap between two fraction doses. As growth of tumor is faster than 
that of normal cells, during this gaps, repopulation of the tumor calls occur. 
So, to combat with some of these strategies, combination of hyperthermia and radiation therapy 
is proposed in this research work. Figure 3.4 shows the effect of combination therapy. 
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Figure 3.4 Effect of tumor microenvironment due to the combination 
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This study has some unavoidable limitations. There is no information about combination of 
hyperthermia and how much radiation dose is possible to reduce actually for a tumor of radius 
4 cm. There are other factors which are important such as determining the time gap between 
two therapies and how that affect the combination therapy. Such factors are important to 
investigate further. 
Many clinical studies were conducted in order to find the advantages of implementing 
combination of radiation therapy with hyperthermia. Dewey et al had concluded the cellular 
effects happens due to high temperature [8]. So it can be expected that the radiation dose 
required would be lesser than the required. Refaat et al, in a recent study of 2015 had performed 
a randomized trial of mostly breast cancer patients included rigorous and thermal dosimetry 
[100]. 109 patients were randomized to radiation and combination of radiation and hyperthermia. 
Patients treated with hyperthermia, were planned for at least a dose of 10 cumulative equivalent 
minutes at 43˚C for 90% of measured points. This was in additional to conventionally 
fractionated external beam radiation therapy of 60-70 Gy.  For the patients who were 
previously irradiated, they received 30-66 Gy radiation dose. The proportion of patients 
receiving systemic treatment at the time did not differ between both arms. The complete 
response rate was significantly higher in patients treated with hyperthermia as opposed to 
radiation dose alone. Local control was also more accessible for hyperthermia, as the tumor 
only was heated. 
The studies shows the rationale of choosing 30 Gy radiation dose for a small tumor of 4cm, 
when combined with hyperthermia. This suggest further investigation on this radiation 
application. 
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Chapter 4: 
 Optimization of the Combination 
 
The literal meaning of the word optimization means choosing the best element over the available 
set of elements. 
The practitioner who adds hyperthermia to radiotherapy and/or chemotherapy, electromagnetic 
fields are used for heating. Loco-regional deep hyperthermia is usually applied by an antenna array 
using constructive interference to deposit sufficient energy at depth, for example for tumors 
located in the lower pelvis [102] or the head and neck region [103]. Control of the electromagnetic 
heating of the tumor is realized by changing amplitudes, phases of the signal on pairs of antennas, 
distance between the antennas. There exists a broad consensus that the clinical efficacy of a 
hyperthermia treatment is correlated to the applied thermal dose [8-10].  
Hyperthermia treatment planning is considered an essential tool to guide SAR steering and to 
increase the thermal dose [104-105]. In a recently published patient study on the effectiveness of 
hyperthermia treatment planning in deep hyperthermia treatments, Franckena et al. showed that 
the use of hyperthermia treatment planning as an objective guide for SAR steering during patient 
treatments leads to temperature results comparable to the conventional, i.e. subjective, method to 
control SAR steering during the treatment [106-107].  
Optimization of the SAR distribution in hyperthermia treatment planning guided steering essentially 
consists of maximizing SAR in the tumor, and minimizing SAR peaks in the healthy tissue, in the 
expectation that this leads to maximization of the tumor temperature. Deep hyperthermia 
treatments are often limited by hotspots [105,108]. The treatment strategy lies always to heat up to 
the discomfort limit, and keeping the RF power as high as possible. Therefore, heat induced 
discomfort in patients is common. Accurate prediction of SAR peaks that would lead to patient 
complaints would offer an elegant method to prevent the occurrence of such complaints. This 
requires however, that a high correlation exists between the predicted SAR peaks and the location 
of patient complaints. Therefore, this study aims at assessing whether predicted SAR peak 
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locations correlate with the locations of the patient complaints. If so, this enables us to use 
hyperthermia treatment planning predicted SAR peak locations as a-priori indicators for the 
occurrence of patient complaints during treatment. This study is a logical follow-up of the 
previously mentioned study of [106]. Further, the translation from model to clinic is very important 
when using hyperthermia treatment planning models. Hence, a sensitivity analysis of the 
hyperthermia treatment planning predictions is performed for factors that may determine the 
quality of this translation: patient positioning, signal of the antennas, dielectric properties, and 
water bolus shape. Water bolus shape is expected to influence SAR patterns [109], but is not included 
in this study. 
Mutual Coupling 
 
Mutual coupling is an electromagnetic phenomenon which exists in many antenna arrays when 
they are placed too close to each other. In most of the usual cases it is detrimental to the antenna 
operation, although there are some examples in which its presence can be beneficial.  
By its nature, mutual coupling exhibits differently in transmitting and receiving antenna arrays and 
therefore has to be treated differently.  
The effect of mutual coupling is serious if the element spacing is small. It will affect the antenna 
array mainly in the following ways [110]: 
 Change the array radiation pattern  
 Change the array manifold (the received element voltages)  
 Change the matching characteristic of the antenna elements  
 
The amount of mutual coupling depends primarily on the following points [111,112]: 
(a) Radiation characteristics of each 
(b) Relative separation between them 
(c) Relative orientation of each 
 
In figure 4.1, change in radiation pattern is explained. 
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Figure 4.1 Change in radiation pattern due to mutual coupling 
 
 
Two of the most important characteristics of an antenna are its input impedance and its radiation 
pattern, both being frequency‐dependent quantities. Mutual coupling simply corresponds to the 
fact that, in view of the presence of another object in the vicinity of the antenna, its near‐field 
radiation pattern is different from the one found when the antenna is isolated in unbounded free 
space. As a result of the change in boundary conditions, new currents (or different equivalent 
currents) appear on the neighboring objects. The currents on the antenna itself, including its port 
current, are also modified. As a result, both the antenna radiation pattern and its input impedance 
change.  
When the neighboring element is another antenna, even passively terminated, currents may flow 
through its termination, such that energy is being dissipated in it. This will, for instance, impose 
constraints on the efficiency of an antenna located in a dense array [112]. When considering an array 
with only one element excited, the neighboring elements may also be regarded as an extension of 
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the excited antenna. The impedance of the resulting antenna is sometimes called the “passive” 
impedance and its radiation pattern is called the “embedded element pattern.”  
A simple approximation to finite array effects on embedded patterns is presented by Kelley and 
Stutzman [113], where a distinction is made between edge and core elements in the array. An N‐
element array can also be regarded as an N‐port device with its own impedance matrix (or, 
equivalently, admittance or scattering matrix). The elements of the N‐port scattering matrix are 
sometimes called the “coupling coefficients.” However, it is important consider, except for special 
cases, the knowledge of the “coupling coefficients” does not provide a complete picture of the 
effects of mutual coupling. This means that, in general, the knowledge of the radiation pattern of 
the isolated element and of the N‐port scattering matrix is not sufficient to obtain all the embedded 
element patterns. 
This was the basic need for making the changes in the distance between the antennas. 
 
4.1 Distance between the Antennas 
Initially in this research work, the distance between two antennas were considered to be 0.5 
centimeters but due to the mutual SAR and temperature effect. 
After checking other distances, 0.5 centimeters distance was found to give a good amount of 
cumulative amount of SAR and temperature generation. 
But in later experiments, it was found that considering 0.5 cm distance between two antennas 
causes mutual coupling. Henceforth, the distance between the catheters were recalculated to get 
rid of mutual coupling effect and at the same time, to get a considerably good amount of mutual 
SAR and temperature effect inside the tumor. 
In chapter 2, the reason behind choosing invasive coaxial-slot antenna over other non-invasive 
antennas was explained and justified. So, it is important to consider the input impedance factor as 
well. If the input impedance factor varies, it becomes difficult for impedance matching and hence 
proper delivery of the current. 
Thus further calculations were required to consider the mutual coupling factor here and hence re-
calculation. 
After calculating the SAR and temperature, a comparative study was done in varying distance 
between two antennas and effect in mutual coupling, mutual SAR and mutual temperature. 
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Here an important thing to note is: More the mutual SAR and temperature effect, it is better. With 
increasing the distance we could see that there is a reduction in mutual SAR and temperature effect.  
On the other hand, more the mutual coupling, it is worse. With increasing distance the mutual 
coupling between the antennas decrease. At 2 cm, the mutual coupling between the antennas was 
not seen. 
2 cm distance was found to be suitable as mutual coupling factor was not affecting the cumulative 
power of the antennas. Though the mutual effect of SAR and temperature was reduced than before, 
but a considerable amount of heating was found.  
 
Discussion on Coherent and Non-coherent system 
 
Normally in electromagnetics, when an antenna array is used, coherent or non-coherent system 
arises. 
(i) Coherent System: When the antennas are used with same power source in an antenna 
array, they emit power with a fixed phase relationship. 
(ii) Non-coherent System: When the antennas are used with different power source in an 
antenna array, they emit power in different phase and they have a phase difference 
relationship.  
For Non-coherent system, mutual coupling factor does not reduce the power. In that case, the 
distance between the antennas in an antenna array can be adjusted to 0.5 cm as it is mentioned 
earlier. In that case, the mutual SAR and mutual temperature effect can be found. 
 
Some research previously done by Denman et al had shown while arranging a four square array, 
heating effect was found in the periphery of the array structure [114]. If such a heating zone can be 
generated by using an array of invasive antenna, then it can be considered beneficial and further 
can be considered. 
As this research work is done by simulating the effects of the antenna inside human like tissue. 
But human tissue has varying characteristics of dielectric properties. Presence of different tissue 
and their lossy characteristics diffracts the signal in between [115].  
The characterizing quantities are radiation pattern and input impedance. As per the experiments, 
the input impedance is 50 ohm and it did not change due to variation in distance between the 
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catheters. This happened due to the dielectric properties of the human tissue. For human tissue, 
mutual coupling factor is not as dominant as mutual coupling factor observed when antennas are 
placed in free space or air. 
In figure 4.2 and 4.3 the mutual SAR and mutual temperature effect of 0.5 cm and 2 cm is shown 
individually. 
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Figure 4.2 SAR effect from antennas placed in 2 cm and 0.5 cm 
 
 
 
 
 
 
Figure 4.3 Temperature effect from antennas placed in 2 cm and 0.5 cm 
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4.2 Effect of 2 cm distance in radiation calculation 
In this research work, the distance between the catheters were optimized to 2 cm in order to avoid 
mutual coupling effect and also to get a considerable amount of SAR and temperature effect.  
In conventional brachytherapy the radiation dose is the cumulative dose of all the probes used for 
brachytherapy.  
As mentioned in chapter 3, about the radiation dose, it is proposed that radio-isotopes would be 
introduced inside the catheter. Thus if the distance between the catheter is changed, that factor 
would also affect radiation dose distribution. 
Radiation dose delivered by conventional brachytherapy machine, the probes are placed near to 
each other. Radiation dose would therefore cumulatively distributed to the adjacent tissues.  
If the distance between the probes which are responsible to distribute the radiation dose are placed 
more distance than each other, the cumulative dose distribution would cover a lesser area. In that 
case, the lesser area would have higher dose of radiation and the harm could be more. 
On the other hand, if the probes or the catheters distributing radiation dose are placed at 0.5 cm 
from each other, then the cumulative radiation dose distribution would cover 4cm area around the 
catheters which is a desired area to be covered by radiation dose. 
Henceforth, the catheters distance which were optimized to 2 cm in order to avoid mutual coupling 
in hyperthermia, is not applicable for radiation dose distribution. Distance between the catheters 
are not therefor optimized for radiation dose distribution. Figure 4.4 shows the effect of radiation 
dose when the catheters are placed 0.5 cm away. 
 
 
 
 
 
 
 
 
 
80 
 
 
Figure 4.4 Effects of 30 Gy radiation dose when catheters are 0.5 cm apart 
 
 
Another case of right breast where the tumor spread was found to be around 5 cm X 3 cm, was 
targeted and 30 Gy radiation dose was applied.  Figure 4.5 shows the radiation dose effect. 
In this later case, the radiation dose effect of 10 Gy was seen to be effective in 5 cm X 3 cm area.  
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Figure 4.5 Effect of 30 Gy radiation dose in right breast tumor of spread 5 cm X 3 cm 
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Chapter 5 
General Discussion  
 
In this chapter, the entire research work is concluded and general discussion part is provided in terms of 
looking up to the future investigation. 
The initial motivation of starting this research work was to treat breast tumors with less harm to surrounding 
normal tissue. In the initial phase of the research work, an extensive research on previous study was done. 
The combination treatment was selected for the further application. 
 
5.1 Advantages of Combination of Microwave Hyperthermia and Radiation Brachytherapy  
There has been considerable interest in the possible applications of hyperthermia to radiation 
therapy [8]. First, the effects of hyperthermia by itself will be considered in terms of:  
(a) Cell killing as a function of temperature and duration of thermal treatment; 
(b) The thermodynamics of heat inactivation;  
(c) Evidence pertaining to the molecular lesions and particular structures inactivated within the 
cell;  
(d) Variations during the cell cycle in sensitivity to hyperthermia;  
(e) Cell recovery following treatment; 
(f) The time required for repair of heat-induced lesions; 
(g) The effects of hypoxia and other physiological states on the hyperthermia response. 
(h) The cell membrane becomes more watery and permeable- the objects which were not able to  
 
Secondly, the effects of hyperthermia in combination with x-irradiation will be considered in 
relation to:  
(a) The effects of heat on the shape of the x-ray survival curve when cells are irradiated either as 
asynchronous populations or in different phases of the cell cycle;  
(b) The effects of different temperature and durations of thermal treatment in relation to the time 
that the heat is applied relative to the x-ray dose;  
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(c) The repair kinetics both for the heat damage interacting with the subsequent x-ray dose and for 
radiation damage interacting with the subsequent heat dose; and 
(d) The effects of hypoxia on combination of hyperthermia and radiation. 
 
These considerations should allow us to define the possible advantages of hyperthermia in cancer 
therapy, and to delineate the specific problems to be resolved in order to determine if hyperthermia 
should be used in such therapy, and if so, most effective use of its protocol. 
An additional advantage of using the combination of interstitial hyperthermia and brachytherapy 
is that the adverse effect on the other tissues adjacent to the breast tumor is minimized because the 
heat and radiation are focused on the breast tumor.  
 
Though in past, the combination of invasive hyperthermia and brachytherapy was tried for cancer 
treatment. But the heating module and non-homogeneity of the heating region made it conclude in 
a quantitative way. 
The temperature over 42.5˚C was examined to be cytotoxic for the tumor region [8]. But the exact 
temperature and amount of radiation was not been optimized till now. The rationale is every human 
and its thermal tolerance differs from each other. 
Even for the computer simulation, during this research work, some difference was found due to 
the boundary conditions applied. 
Figure 5.1 shows the effect of temperature in normal cells and tumor cells. 
 
 
 
 
84 
 
 
Figure 5.1 Comparative results between tumor cells and normal cells due to temperature 
 
 
 
There could be several conditions where combination shows to be effective on cancerous cells. 
 
Another advantage of this proposed method is the thermal sensor. The introduction of thermal 
sensor is added advantage as temperature can be monitored from outside and according to patient’s 
need, the temperature can be increased. 
Even during the time lag between two therapies, the amount of temperature decrease can be 
monitored by the thermal sensors. 
 
In figure 5.2, the whole set up for hyperthermia is shown. 
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Figure 5.2 Whole experimental set up for hyperthermia using invasive antenna arrays 
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5.2 Advantages of Microwave Hyperthermia 
 
Cancer hyperthermia is a treatment to raise the tissue temperature either locally or whole body to 
a therapeutic level to eradicate tumors. Over the last three decades, much has been learned about 
the effects of heat on cells and the interactions between heat and radiation and chemotherapeutic 
agents [8-14]. The scientific rationale for its use either alone or combined with other methods is 
multifactorial, and new justifications for its use are continuously being identified. For example, 
heat may be directly cytotoxic to tumor cells or inhibit repair of both sublethal and potentially 
lethal damage after radiation. Hyperthermia has been used in combination with chemotherapy 
because heating increases membrane permeability and the potency of some drugs. The synergism 
of radiation and hyperthermia is accomplished by the thermal killing of hypoxic and S phase (DNA 
syntheses) cells which are resistive to radiation alone. Although the biologic rationale is strong, 
and hyperthermia has been studied in phase I-III trials, the results of phase III clinical trials are 
controversial and the use of hyperthermia is still a developing project in all over the world.  
Numerous factors could affect the results of hyperthermia. The foremost problem in hyperthermia, 
however, is the generation and control of heat in tumors. Current heating methods include whole 
body heating, using hot wax, hot air, hot water suits, or infrared radiation, and partial body heating, 
utilizing ultrasound, heated blood, fluid perfusion, radio frequency (RF) fields, or microwaves. 
The effective temperature range of hyperthermia is very small: 42 to 45°C. At lower temperatures, 
the effect is minimal. At temperatures higher than 45°C, normal cells are damaged. Due to this 
narrow temperature range, the response rate of the tumor is highly dependent on how much of it 
is heated to a therapeutic level. The clinical use of hyperthermia has been hampered by a lack of 
adequate equipment to effectively deliver heat to deep-seated and even large superficial lesions 
and by a lack of thermometry techniques that provide reliable information on heat distribution in 
the target tissues. In RF hyperthermia, the final temperature of tumors is mainly dependent on 
energy deposition. When electromagnetic (EM) heating methods are used, the energy deposition 
is a complex function of the frequency, intensity, and polarization of the applied fields, the 
applicator’s size and geometry, as well as the size, depth, geometry, and dielectric property of the 
tumor [9,10]. The material, thickness, and construction of a cooling bolus also influence the amount 
of energy deposition. In this chapter, the main methods of RF hyperthermia will be reviewed. 
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Microwave: 
 
The EM energy used in hyperthermia is usually classified by frequency as either microwave energy 
or RF energy. Microwaves occupy the EM frequency band between 300 MHz and 300 GHz. 
Strictly speaking, RF is between 3 kHz and 300 GHz, but for hyperthermia it generally refers to 
frequencies below the microwave range. The most commonly used microwave frequencies in 
hyperthermia are 433, 915, and 2450 MHz, which are the designated ISM (industrial, scientific, 
and medical) frequencies in the Japan, U. S. and Europe. Common RF frequencies are 13.56 and 
27.12 MHz, which have also been widely used in diathermy. Frequencies higher than 2450 MHz 
have no practical value due to their limited penetrations. At lower frequencies field penetration is 
deeper, but the applicator must be larger and focusing is difficult. Despite these limitations, EM 
heating methods have been developed for local, regional, and whole body hyperthermia. 
 
Interstitial Hyperthermia: 
Interstitial techniques for radiation implants as primary or boost treatments have been practiced 
successfully by radiation oncologists for many years. When hyperthermia was learned to be 
cytotoxic and synergistic with radiation, it was natural to consider this combination with 
conventional interstitial radioactive implantation. The advantages of this technique over external 
hyperthermia include confined treatment volume, better sparing of normal tissue, and accessibility 
of deeper tumors, more homogeneous therapeutic temperature distribution, and better control and 
evaluation of thermal parameters. Interstitial hyperthermia has been used for various site tumors; 
however, a phase III study of interstitial thermo-radiotherapy for recurrent or persistent human 
tumors did not show any additional beneficial effects over interstitial radiation alone. The delivery 
of hyperthermia remains a major obstacle [46, 113-116]. Methods such as resistive heating, the 
microwave technique, or ferromagnetic seed implants can be used for interstitial hyperthermia. 
With resistive heating, multi-electrodes inserted in plastic tubes were implanted in the treatment 
volume. The mean power deposition of the individual electrodes was controlled by varying the 
duty cycle of the RF signal applied to the electrodes [117]. To prevent excitation of nerve action 
potentials, an operating frequency greater than 100 kHz should be used. The microwave technique 
utilizes small microwave antennas inserted into hollow plastic tubing to produce interstitial heat. 
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In the U. S., 915 MHz is a commonly used frequency for this technique. However, satisfactory 
heating patterns can be produced between 300 and 2450 MHz [118]. A small coaxial antenna can 
irradiate a volume of approximately 60 cc. In a brain hyperthermia study, the array of four dipole 
antennas spaced 2.0 cm apart were capable of heating a volume of 5.9 cm x 2.8 cm x 2.8 cm [119]. 
As in RF resistive hyperthermia, the degree of control of microwave power radiating from these 
antennas is important in order to achieve homogeneous heating. Since the antennas couple to each 
other, the spacing, phasing, and insertion depth affect the heating patterns of array applicators [120-
121]. 
Interstitial heat can also be produced by using ferromagnetic seed implants. This technique is 
applicable for delivering thermal energy to deep-seated tumors. The seed characteristics and 
implant geometry must be determined prior to the treatment [122]. When exposed to RF magnetic 
fields (~100 kHz), the implants absorb power and become heated until they reach the Curie point. 
Here, the implants become non ferromagnetic and no longer produce heat. The surrounding tissues 
are then heated by thermal conduction. The influence of blood flow and tissue inhomogeneity of 
the tumor, which may affect the temperature distribution, can be compensated by the self-
regulation of the implants. It is therefore possible to maintain a temperature close to the Curie point 
[123-124]. Another method, which exposes magnetic fluid in a tumor to an RF magnetic field (0.3 to 
80 MHz), has also been shown to be feasible for inducing selective heating [125]. Cetas et al. [126] 
developed an alternative form of ferromagnetic seed. A nearly lossless ceramic ferrite core (FC) 
is surrounded by an electrically conductive metallic sheath (MS).  
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5.3 Advantages of Brachytherapy 
Brachytherapy is a method of delivering radiation to tumors by placing radioactive sources either 
within or immediately adjacent to tumor tissue. Because the radiation source is very close to the 
tumor, therapeutic radiation can affect the tumor directly while minimally affecting normal tissue. 
Brachytherapy can be provided using low dose rate (LDR) or high dose rate (HDR) techniques, 
depending on the length of time the radioactive sources remain in place. 
 
During this research work, in the initial phase different antennas, namely micro-strip patch antenna, 
spiral antenna and coaxial-slot antenna was designed and applied on human tissues to check the 
accessibility and also the temperature achieved. As coaxial-slot antenna was chosen for heating 
deep seated tumors with less heating of surrounding normal tissues, consequently brachytherapy 
was also chosen for further calculations. 
A huge research work has undergone for treating breast tumors and doses are always considered 
to be high in order to treat the tumor.  
During this research work, there were discussions with medical doctors who are specialized in 
radiation therapy and according to them, the medical doctors prioritize treating the tumor than 
counting the hazard of high radiation dose. In many cases, secondary tumors occurs due to the 
previously irradiated with high radiation dose. 
Whelan et al [92] reported prominent results (regarding local control, survival, and post-radiation 
effects) between the standard fractionation schedule of 50 Gy in 25 fractions and a hypo 
fractionated scheme of 42.5 Gy in 16 fractions over 22 d for women with node-negative early 
breast cancer. 
Though it is an extensive area to look upon. For this research work, 30 Gy divided in 5 fractions, 
each having 6 Gy was decided. Further calculations and simulations were done on that basis. 
Because during this research work, the whole work was done on simulation only, thus the harm or 
hazards could not be concluded. 
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5.4 Effects of Blood Flow 
Blood flow is an important parameter in this research work which was not considered in the 
phantom experiments. 
There are two dependencies are found. 
(i) Hyperthermia’s effect on blood flow 
(ii) Blood flow’s effect on hyperthermia 
 
For the first case of hyperthermia’s effect on blood flow, the characteristics are found to vary from 
normal tissue to tumors [134]. The variation is characterized in table 5.1. 
 
Table 5.1 Variation of blood flow in different tissue due to hyperthermia 
Tissue Type Hyperthermia’s Effect on Blood Flow 
Tumor Blood flow initially increases with increase in 
temperature, but later returns to normal [134] 
Normal tissue 
 
Blood flow increases with temperature [134] 
 
 For the second case mentioned above, every tissue inside the human body are enriched with blood 
vessels and normally blood is known as a thermo regulator. Previous research had shown that due 
to the equilibrium created by blood flow, it becomes more difficult to increase up to desirable 
temperature [93].  
Blood flow term is a scalar property. In fact, blood flow in a tissue usually has a direction from 
the artery to vein passing through the capillary bed. Furthermore, the blood and its surrounding 
tissues are not in thermal equilibrium when the blood vessel diameter is larger than 200 μ meter. 
This means the equation for tissue and blood large vessels must be treated individually.  Equation 
(1) gives the equation for tissue and equation (2) gives the equation for blood vessels. 
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Where, T(r,z,t) = temperature that is distributed axis symmetrically 
 𝜌 = density 
 𝐾 = thermal conductivity 
 𝑐 = specific heat 
 𝑄(𝑟, 𝑧, 𝑡) = power of heat added axis symmetrically 
 𝜔𝑏 = perfusion mass flow rate 
 𝑇𝑎 = ambient temperature (37˚C) 
 𝜔(𝑟, 𝑡) = axial velocity of bloof flow 
 𝑄𝑚 = neglected 
The heat sink in equation (1) is used to describe the perfusion effect by the microvascular network 
of blood flow, while the heat transfer due to thermally significant large blood vessels has to be 
separately described in equation (2).  
One of the key issues in thermal treatment is blood flow usually drains out the heat from the heating 
region, which causes insufficient thermal dose in the targeted volume. More the volume of the 
target, more will be difficult to increase the desired temperature. The differential therapeutic effect 
of thermal treatments between malignant and normal tissue may primarily depend on vascular 
characteristics of the tumor. 
It is of interest to not only consider simple steady uniform or parabolic blood velocity profile, but 
also the pulsatile blood flow in thermally significant blood vessels, (larger than 200 μ meter  in 
diameter) with the assumptions that the blood vessel segment is straight, the vessel wall is rigid 
and impermeable and the flow is incompressible and Newtonian.  
Considering the steady blood flow passing through a rigid vessel of inner radius r0, the axial 
Hagen-Poiseuille velocity profile can be expressed as equation (3): 
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𝜔(𝑟) = −
1
4𝜇
(𝑟0
2 − 𝑟2)
𝑑𝑝
𝑑𝑧
                                                                (3) 
 
Where, μ = dynamic viscosity 
 𝑟0 = inner radius 
 𝑟 = outer radius 
 𝑑𝑝/𝑑𝑧 = constant pressure gradient along the axial z direction 
 
Whether the tumors are preferentially heated and thus preferentially damaged by hyperthermia 
depends largely on the relative rate of heat dissipation by blood perfusion in the tumors and normal 
tissues. In some experimental tumors, the blood flow increases before vascular collapse occurs 
upon heating. Usually, the increase in tumor blood flow is less than 2-fold. 
The clinical observations that temperatures in human tumors rise higher than that in the 
surrounding normal tissues may also be attributed to sluggish blood flow in the tumors relative to 
that in the normal tissues. However, blood flow in certain tumors would remain greater than that 
in the normal tissue, despite the greater degree of increase in normal tissue blood flow during 
heating. It would be difficult to raise the temperatures in such tumors higher than that in the normal 
tissues. It is conceivable that certain areas in a tumor are poorly vascularized, and thus the 
temperature in such areas rises higher than in the surrounding well-vascularized areas or normal 
tissues. The tumor cells in such poorly vascularized areas might be radio biologically hypoxic, and 
thus radio resistant, while these cells may be selectively killed by hyperthermia owing to the 
preferential rise in temperature and also to the acidic environment associated with the hypoxic 
condition. Changes in blood flow rate during the course of fractionated heating as well as the effect 
of combined use of radiation or drugs with heat on the blood flow rate remain to be elucidated. 
In this research work, this parameter was not considered thoroughly and it can be understood that 
it plays a major role in the holistic approach of hyperthermia. Thus in future, this parameter needs 
to be considered for conclude more substantially. 
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Chapter 6 
Conclusion and Future Work 
 
6.1 Summary 
This study was started in order to treat breast tumor with the combination therapy and possible less 
harm to the surrounding tissues. Despite of extensive research work on this combination in the 
past, there was no quantitative and conclusive results for breast tumors. That is why this study was 
initiated. 
 These phantoms were made of agar material, polyethylene powder, Sodium chloride and distilled 
water. These phantoms were mostly made planar and oval shaped for making it realistic like breast 
structure. 
Hyperthermia: 
Biological effect of hyperthermia: 
The cell killing property of hyperthermia depends on various cellular factors [53]: 
Cell cycle: Synchronized cell cultures exhibit variations in their susceptibility to heat in 
accordance to their phase in the cell cycle. In general, the highest heat sensitivity can be observed 
during the mitotic phase. Microscopic examinations of M-phase cells exposed to hyperthermia 
show damage of their mitotic apparatus leading to insufficient mitosis. S-phase cells are also 
sensitive to hyperthermia, where chromosomal damage is observed. Both S and M-phase cells 
undergo a ‘slow mode of cell death’ after hyperthermia, whereas those exposed to heat during G1-
phase are relatively heat resistant and do not show any microscopic damage. These variations 
existing between the different cell cycle phases indicate the possible diversity of molecular 
mechanisms of cell death following hyperthermia. 
 
Effects in DNA and RNA: Intracellular synthesis and polymerization of both RNA and DNA 
molecules as well as protein synthesis are decreased in vitro at temperatures over 42.5˚C in a dose 
dependent manner. Whereas RNA and protein synthesis recover rapidly after termination of heat 
exposure, DNA synthesis is inhibited for a longer period. Heat shock induces an aggregation of 
denatured proteins at the nuclear matrix. This is mainly due to insolubility of cellular proteins after 
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heat induced protein unfolding, entailing an enhancement of the nuclear protein concentration. 
Increase of the nuclear protein concentration. Increase of the nuclear protein content by heat 
consequently affects several molecular function (including DNA synthesis and repair) when a 
certain thermal dose is exceeded. This threshold dose varies with different cell lines. 
In the first phase of research work, hyperthermia was the main objective where heating the tumor 
and finding the appropriate set of antenna with optimum parameters were main challenge. For 
hyperthermia, different antennas and different phantoms having similar dielectric values to human 
tissue were designed. After conducting the experiments in phantoms and simulations, the results 
were emphasized. In chapter 3 and 4 had shown the comparative and quantitative results. From 
there, invasive antenna was found to be suitable for this research work and also serve the initial 
objective. Interstitial hyperthermia applied using a coaxial-slot antenna increases the temperature 
of the tumor tissues to over 42.5˚C in 30 min of heating. A coaxial-slot antenna array was used in 
such a way that the temperature increase takes place in a localized area with minimal effect on the 
adjacent tissues. After increasing the temperature of the breast tumor to over 42.5˚C, a lower dose 
of radiation is expected to be effective for treatment. 
The Initial motive was to find the antenna and setting the array structure. Initially 0.5 cm distance 
was found to be decisive as it was giving a cumulative SAR effect and temperature elevation. 
During that work, mutual coupling factor was not considered. 
One of the important factor which was not considered during the experiments in simulation was 
blood flow in the tumor during hyperthermia and effects of blood flow for hyperthermia. 
Considering that, the calculation, time required and power mentioned in this research may vary to 
some extent [60]. 
 
Song et al, investigated the effect in blood flow in tumors and concluded that, the blood flow in 
tumors varies considerably among different tumor types [127]. Even in the same tumor, the 
distribution of vasculature and blood flow is quite heterogeneous. The tumor blood flow generally 
decreases as the tumors grow larger, owing partially to progressive deterioration of vascular beds 
and to the rapid growth of tumor cell population relative to vascular beds. Contrary to the general 
notion that blood flow is less in tumors than in normal tissues, blood flow in many tumors, 
particularly in small tumors, is actually greater than that in surrounding normal tissues at normal 
thermal conditions. Compared to the normal tissue blood flow, however, the capacity of tumor 
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blood flow to increase upon heating appears to be rather limited. Consequently, the heat dissipation 
by blood flow in tumors is slower than that in normal tissues, and thus the temperature of tumor 
rises higher than that in normal tissue during heating. Preferential heating of tumors, however, may 
not be achieved all the time because the relative blood perfusion in some tumors remains greater 
than that in the surrounding normal tissues despite the profound increase in normal tissue blood 
flow during heating. The vasculature in tumor can be significantly damaged at temperatures which 
may alter but do not damage the vasculature of normal tissue. Upon heating, the inside the tumor 
environment becomes acidic, hypoxic, and nutritionally deprived due probably to vascular damage. 
Such a suboptimal environment in the heated tumors potentiates the response of tumor cells to 
hyperthermia, inhibits the repair of thermal damage, and also interferes with the development of 
thermal tolerance. The acidic environment also appears to potentiate the response of tumor cells 
to certain drugs at elevated temperatures. The changes in oxygenation of tumors and normal tissues 
caused by the changes in blood flow may have significant implications in the effectiveness of 
different sequences of hyperthermia and radiotherapy in the combined use of these two modalities. 
Changes in the distribution of drugs in tumors and normal tissues due to changes in blood flow 
will also determine the optimal use of hyperthermia in conjunction with chemotherapy. 
It is a well-known fact that heat induces a prompt increase in blood flow accompanied by dilation 
of vessels and an increase in permeability of the vascular wall in normal tissues [126]. The degree 
of pathophysiological changes in the vascular system in normal tissue is, of course, dependent on 
temperature and duration of heating. An excess exposure of tissues to heat results in a breakdown 
of vasculature followed by necrosis of the tissues. Information on the vascular changes in normal 
tissues at temperatures commonly used in clinical hyperthermia, i.e., 41-45˚C. 
Hyperthermia is a complicated technique and should be applied only by individuals well trained 
in its use. Due to the complexity of EM energy coupling to human tumors, careful heating pattern 
studies should be performed on all exposure geometries and contingencies prior to treatment to 
assure the best treatment conditions for the patient. Since hyperthermia in combination with high 
energy radiotherapy cannot be repeated after the tumor receives a maximal dosage of ionizing 
radiation, the physician must try to reach the critical tumor temperatures in optimal conjunction 
with radiotherapy. Accurate thermometry is particularly important in all phases of clinical 
hyperthermia, especially when the patient is anesthetized. The benefit of a good treatment 
outweighs minor risks. If there is no other choice, it would be more beneficial for the patient to 
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have an effective treatment with a few blisters rather than a safe but ineffective treatment. It is 
easier to treat the burns than the cancer. 
In this research work, two major categories of antenna are designed in hyperthermia to heat the 
tumor: non-invasive and invasive. In the early phases of this research work, non-invasive antennas, 
namely, micro strip patch antenna and spiral antenna, were designed and tested on different types 
of phantom. The heating and depth of penetration were better in the case of spiral antenna as 
compared to micro-strip patch antenna. While both the non-invasive antennas gave good results 
for heating of a superficial tumor few centimeters beneath the skin, there was limited or no impact 
on deep-seated tumors. There was also a possibility of ablation of skin and other tissues adjacent 
to the tumor. 
As mentioned in the chapter 2, non-invasive antennas were used for heating the superficial tumors 
which were located around 2-3 cm below the skin layer. During the experiments, non-invasive 
antennas were used to add their effects and then focus on a tumor which is located deeper than 
3cm, but it was not effective due to high diffraction from human tissue.  
As this research work was focused on deep seated tumors, coaxial-slot antenna was chosen for 
further analysis. For coaxial-slot antenna the risk of effects on normal tissue due to high 
temperature such as skin ablation, can be avoided. Another advantage of using coaxial-slot antenna 
is, there is no requirement of using bolus material for coaxial-slot antenna.  
 
Radiation Biology: 
Radiation biology, or radiobiology, is the study of the effects of radiation on living systems. 
Absorbed radiation dose is an important quantity when predicting the biological effect. However, 
there are many factors that affect the biological response to a given dose: the inherent radio-
sensitivity of the biological system studied, the degree of oxygenation, the dose distribution within 
the irradiated volume, the way dose is fractionated, e.g. dose per fraction, the time between 
fractions, overall treatment time, etc.  
On the other hand, brachytherapy is well practiced by many doctors for treating cancers. Though 
it is an invasive way to treat the tumors but locally given radiation dose harms comparatively lesser 
to the surrounding normal tissues than external beam radiation therapy in which the whole breast 
is irradiated. Evidences of brachytherapy and its catheters are well researched and commercialized. 
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Organ and tumor response to radiation 
 Clinical radiation biology often focuses on the relationship between the absorbed dose and 
resulting response, and on factors influencing this relation. The response in often described as a 
probability of a specific outcome for the normal tissue or the tumor, typically showing a sigmoid 
dose-response curve. Tissues can be classified as serial or parallel, or somewhere in between, based 
on how their functional subunits are organized. Serial tissues, such as the spinal cord and brain 
stem, may lose their function even if only a small proportion is severely damaged. Parallel tissues, 
such as lung and liver, can function even when substantial parts are damaged. Tumors are always 
assumed to have a parallel function since all clonogenic cells need to be eradicated in order to 
achieve tumor control. The response of normal tissues can also be divided into early and late 
occurring damage, reflecting the time of occurrence of side effects. Rapidly dividing tissues such 
as skin, bone-marrow, and intestinal epithelium respond early to radiation. Late-responding tissues 
are for example spinal cord, lung, and kidney.  
 
Dose fractionation  
Dose fractionation is the practice of dividing the therapeutic dose into smaller doses delivered over 
a period of time. It is a key determinant of the therapeutic response. The rational of fractionation 
is that normal tissues are well-organized and have well-functioning repair systems and may 
therefore repair radiation-induced damage to some extent between the fractions, whereas tumors 
are more chaotic in their structure and generally less capable of repair. Another reason is that the 
fast and poorly organized tumor growth often leads to poor vascular networks resulting in 
insufficient oxygen levels. Poor oxygenation results in radio resistant cells [8]. After the delivery 
of dose fractions, the oxygen supply may be improved by hypoxic cells turning toxic due to 
eradication of the more toxic, radiosensitive, tumor cells or through the reopening of previously 
closed blood vessels [128]. The main biological processes that affect the fractionation effect are 
summarized by the five R’s of radiobiology: 
 
98 
 
1. Repair: Repair is one of the primary reasons for fractionation. The smaller dose fractions 
separated in time allow normal tissue to recover, and normal tissue with intact repair capacity 
generally has a better ability to repair damage than tumors.  
2. Redistribution: Cells in some phases of the cell cycle (M and G2) are more radiosensitive than 
in other (S). Dose delivery over time allows for redistribution so that tumor cells in a resistant 
phase continue to cycle into a more sensitive phase.  
3.  Re oxygenation: Tumor hypoxia is a condition where tumor cells are deprived of oxygen 
making them more radio resistant than well oxygenated cells. The oxygenation status may 
change during treatment and dividing the dose may allow more tumor cells to be eradicated.  
4. Repopulation: A prolonged treatment allows normal cells to proliferate which is beneficial. 
However, also tumor cells proliferate and, especially for fast growing tumors, a too long 
treatment time may lead to tumor regrowth. 
5. Radio sensitivity: There is also an intrinsic radio sensitivity depending on cell type. Late-
responding tissues are more sensitive to changes in fractionation patterns than early-
responding tissues. The difference between these tissues in their response to changes in 
fractionation could be understood from the differences in their dose-response relations. The 
cell survival curve for late-responding tissues, with its more curved shape compared to early-
responding tissues after photon irradiation, show more sparing when the dose is fractionated. 
Fewer and larger dose fractions result in more severe late effects even when the total dose is 
adjusted to produce equal early effects. The response following high-LET radiation, with 
generally straighter cell survival curves, is consequently less affected by fractionation.  
 
Table 6.1 shows the comparative results of alone radiation dose required and combination of 
hyperthermia and radiation dose 
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Table 6.1 Comparative result of radiation dose with or without hyperthermia 
 Radiation Dose Effect alone Combination of Hyperthermia and 
Radiation Dose Effect 
Breast Tumor 
 
50-60 Gy 30 Gy (proposed) 
Duration 
 
Longer Comparatively shorter 
Cost Expensive Linac Comparatively cheaper  
(RF machine and commercial 
brachytherapy) 
 
 
Dewey et al had concluded the cellular effects happens due to high temperature [8]. So it can be 
expected that the radiation dose required would be lesser than the required. Refaat et al, in a recent 
study of 2015 had performed a randomized trial of mostly breast cancer patients included rigorous 
and thermal dosimetry [100]. 109 patients were randomized to radiation and combination of 
radiation and hyperthermia. Patients treated with hyperthermia, were planned for at least a dose 
of 10 cumulative equivalent minutes at 43˚C for 90% of measured points. This was in additional 
to conventionally fractionated external beam radiation therapy of 60-70 Gy.  For the patients who 
were previously irradiated, they received 30-66 Gy radiation dose. The proportion of patients 
receiving systemic treatment at the time did not differ between both arms. The complete response 
rate was significantly higher in patients treated with hyperthermia as opposed to radiation dose 
alone. Local control was also more accessible for hyperthermia, as the tumor only was heated. 
The studies shows the rationale of choosing 30 Gy radiation dose for a small tumor of 4cm, when 
combined with hyperthermia. This suggest further investigation on this radiation application. 
The whole realization of this project is emphasized in figure 6.2. 
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Figure 6.2 Realization of the holistic approach on this research 
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6.2 Conclusion 
For Hyperthermia, invasive and non-invasive antenna was initially designed and human tissue like 
phantoms. 
For this research work, three types of antenna were designed. Among which coaxial-slot antenna 
gave the best result for heating deep seated tumors.  
After application of the coaxial-slot antenna array, the temperature rise was found to be around 
12˚C, after 30 minutes.  
Among all mentioned, as the research work was focused on the deep seated tumors, coaxial-slot 
antenna was chosen. Subsequently radiation brachytherapy was chosen in order to use the same 
catheter. 
The advantage of using same catheter for both hyperthermia and radiation brachytherapy was to 
avoid many penetration which cause to medical practitioner and also avoidable by the patient. 
After hyperthermia, the antenna could be withdrawn and the catheter remain in the same place. 
Then, the radio-isotopes are introduced in the same catheters.  
The distance between the antenna array was optimized to 0.5 cm, which gave the best mutual SAR 
and temperature effect as mentioned in chapter 4.  This distance was maintained for radiation 
brachytherapy application as well.  
In radiation therapy, a CT image of anonymous patient of breast tumor was used for the simulation 
calculation. After verifying with different radiation dose, 30 Gy radiation dose was found to be 
effective in the area of 4cm X 3 cm which is also target area for hyperthermia. The dose is 
fractionated in 5 fractions and each having 6 Gy radiation dose. 
The radiation dose was found to be effective in the tumor area. The initial objective of the research 
work was to treat the deep seated tumors with lesser radiation dose than conventional radiation 
dose. Also, with possibly lesser effect to the adjacent tissues. At the end of this research work, the 
radiation dose was reduced comparatively to the radiation dose used in external beam radiation 
therapy.  
This reduction was possible as the temperature of the tissue is increased and whole combination 
treatment was done locally. 
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6.2 Conclusion 
(i) For Hyperthermia, invasive and non-invasive antenna was initially designed and human 
tissue like phantoms. 
For this research work, three types of antenna were designed. Among which coaxial-slot 
antenna gave the best result for heating deep seated tumors.  
After application of the coaxial-slot antenna array, the temperature rise was found to be 
around 12˚C, after 30 minutes.  
Among all mentioned, as the research work was focused on the deep seated tumors, 
coaxial-slot antenna was chosen. 
(ii) In radiation therapy, a CT image of anonymous patient of breast tumor was used for the 
simulation calculation. After verifying with different radiation dose, 30 Gy radiation dose 
was found to be effective in the area of 4cm X 3 cm which is also target area for 
hyperthermia. The dose is fractionated in 5 fractions and each having 6 Gy radiation dose. 
The radiation dose was found to be effective in the tumor area. The initial objective of the 
research work was to treat the deep seated tumors with lesser radiation dose than 
conventional radiation dose. Also, with possibly lesser effect to the adjacent tissues. At the 
end of this research work, the radiation dose was reduced comparatively to the radiation 
dose used in external beam radiation therapy.  This reduction was possible as the 
temperature of the tissue is increased and whole combination treatment was done locally. 
(iii) For combination of both the therapies, it is proposed to use the same catheter for 
hyperthermia and radiation brachytherapy. The advantage of using same catheter for both 
hyperthermia and radiation brachytherapy was to avoid many penetration which cause to 
medical practitioner and also avoidable by the patient. After hyperthermia, the antenna 
could be withdrawn and the catheter remain in the same place. Then, the radio-isotopes are 
introduced in the same catheters.   
The distance between the antenna array was optimized to 0.5 cm, which gave the best 
mutual SAR and temperature effect as mentioned in chapter 4.  This distance was 
maintained for radiation brachytherapy application as well.  
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6.3 Future Prospects of this Research Work 
For this work, there is much requirement to continue this work. 
• Real experiments (e.g. on phantoms) of radiation brachytherapy with hyperthermia 
• Study the effect of blood flow in hyperthermia 
• Optimize the combination of hyperthermia and radiation brachytherapy 
• Study the effect of applying hyperthermia and brachytherapy simultaneously and effect of 
time lag between application of the two treatments 
• Conduct experiments on real animals and tumor cells 
• Extend the study of the combination treatment to other type of tumors 
 
First of all, the experiments in phantoms, need to be performed in animals, to see the practical 
effects and also the blood flow effect during hyperthermia. 
Once the experiments are conducted, there could be some requirements of optimizing the antenna 
parameters. 
The second part of this research work is only limited to radiation simulation only. To verify and 
see the actual cellular effects of 30 Gy on a tumor cell along with hyperthermia and without 
hyperthermia- it is essential do to some further experiments. 
Till now the some fundamental background study and antenna and radiation cumulative dose is 
decided, but it needs further work to conclude more quantitatively to conclude this results. 
One of the important parameter is to find the material which could be used for catheters making 
which can withstand the temperature rise and radiation dose inside the human body.  
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Appendix A 
Finite integration Method 
 
The computational time-domain modeling of different types of wave-field problems is utilized in 
various disciplines of engineering and science: in increasingly challenging problems in remote 
sensing, communications, optics, geophysical exploration, ground-penetrating radar, medical 
diagnosis, and nondestructive evaluation.  
Various numerical techniques are applied today to model transient wave fields in  electromagnetics, 
for instance,  
(1) Finite-Difference (FD),  
(2) Finite-Element (FE), 
(3)  Finite Volume (FV),  
(4) Finite-Difference Time-Domain (FDTD),  
(5) Finite-Integration (FI), and  
(6) Finite Volume Time-Domain (FVTD)  
(7) Microcell Time Domain (MCTD)  
 
For this research work, Finite Integration Technique was used in CST software for calculation of 
SAR and temperature when electromagnetic wave was applied. 
In time-domain electromagnetics, the resulting discrete grid equations of FIT are, at least in “some” 
cases, identical to the discrete equations derived with the classical Yee method. This was 
introduced in the mid-1960s [129], and uses a coordinate-based staggered grid system and the 
famous Yee cell. In general, FIT includes the Yee method as a subset. In contrast to FIT, which is 
applied to the integral form of the field equations, the original Yee method is applied to the 
differential form of the governing equations: in electromagnetism, to the Maxwell curl equations 
[55]. 
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The governing field equations of electromagnetics in differential form: 
 
𝜕𝐵(𝑅,𝑡)
𝜕𝑡
=  −∇ × 𝐸(𝑅, 𝑡) − 𝐽𝑚(𝑅, 𝑡)       (1) 
𝜕𝐷(𝑅,𝑡)
𝜕𝑡
= ∇ × 𝐻(𝑅, 𝑡) − 𝐽𝑒(𝑅, 𝑡)       (2) 
Where, B (Vs/m2): Magnetic Flux vector 
  E (V/m): Electric field strength vector 
 Jm(V/m
2): Magnetic current density vector 
 D (As/m2): Electric flux density vector 
 H (A/m): Magnetic field strength vector 
 Je (A/m
2): Electric current density vector 
These are Maxwell’s equation for electromagnetic waves.  
The next equations are characterizing properties of the underlying materials.  
𝐷(𝑅, 𝑡) = 𝜀(𝑅). 𝐸(𝑅, 𝑡)        (3) 
𝐻(𝑅, 𝑡) =  𝜗(𝑅). 𝐵(𝑅, 𝑡)        (4) 
Where 
Ԑ (As/Vm): Permittivity 
𝜗(Am/Vs): Reluctivity 
 
For inhomogeneous materials with interfaces or for boundary-value problems, it is essential that 
the underlying transition/continuity or boundary conditions are insured.  
Suppose two media, with different materials are separated by an interface, I, with unit-normal n 
pointing from medium 1 into medium 2; then, for I∈R, for such situation [129,130]: 
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𝑛 × 𝐸2(𝑅, 𝑡) − 𝑛 × 𝐸1(𝑅, 𝑡) = {
−𝐾𝑚(𝑅, 𝑡)
0
}     (5) 
𝑛 × 𝐻2(𝑅, 𝑡) − 𝑛 × 𝐻1(𝑅, 𝑡) = {
𝐾𝑒(𝑅, 𝑡)
0
}      (6) 
Km (V/m): Magnetic surface current density vector 
Ke (A/m): Surface density of electric current vector 
In general, these surface sources on the right hand side equations are field independent sources. If 
medium (1) is replaced by a medium that is field-free, boundary conditions are needed for the 
fields, which are directly obtained from above equations by deleting all field quantities with a 
superscript (1) and dropping the superscript (2). Then, the interface sources on the right-hand side 
of above equations vanish or define field-dependent sources. 
 
 
 
 
 
 
 
 
 
 
With interface sources 
Source free 
With interface sources 
Source free 
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For the utilization of the Finite Integration Technique, the governing field equations, Equations 
(1) and (2) in integral form by making use of Gauss’ and Stokes’ integral theorem, and insert the 
constitutive equations, Equations (3)-(4), as well as adding time-integration schemes: 
∬ 𝐵(𝑅, 𝑡)
𝑆
. 𝑑𝑠 = ∮ 𝐸(𝑅, 𝑡). 𝑑𝑅
𝐶=𝜕𝑆
− ∬ 𝐽𝑚(𝑅, 𝑡)𝑆 . 𝑑𝑠    (7) 
𝐵(𝑅, 𝑡) = 𝐵(𝑅, 𝑡0) + ∫ 𝐵(𝑅, 𝑡
⋆)𝑑𝑡⋆
𝑡
𝑡0
      (8) 
∬ 𝜀(𝑅). 𝐵(𝑅, 𝑡)
𝑆
. 𝑑𝑠 = ∮ 𝜗(𝑅). 𝐵(𝑅, 𝑡). 𝑑𝑅
𝐶=𝜕𝑆
− ∬ 𝐽𝑒(𝑅, 𝑡)𝑆 . 𝑑𝑠  (9) 
𝐸(𝑅, 𝑡) = 𝐸(𝑅, 𝑡0) + ∫ 𝐸(𝑅, 𝑡
⋆)𝑑𝑡⋆
𝑡
𝑡0
       (10) 
This is the basic of the calculation of CST simulation software which was used in this research 
work to calculate SAR and temperature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 
 
 
Paper:  
1. “Interstitial Hyperthermia in Combination with Radiation Brachytherapy for 
Treatment of Breast Tumor”, Oiendrila Bhowmik Debnath, Kazuyuki Saito, Koichi Ito 
and Mitsuru Uesaka (Accepted in Journal of Thermal Medicine) 
 
International Conference and proceedings: 
1. International symposium on Biotech and Global Warming, 2012 (Oral Presentation) 
Oiendrila Bhowmik , “Detection of early symptoms of Alzheimer’s disease from EEG 
signals”  
 
2. International Microwave Workshop Series on RF and Wireless Technologies for 
Biomedical and Healthcare Applications, 2015 (Oral Presentation) 
Oiendrila Bhowmik Debnath, Kazuyuki Saito, Koichi Ito and Mitsuru Uesaka, “Design 
of invasive and non-invasive antennas for the combination of microwave-hyperthermia 
with radiation therapy”. 
 
3. International Symposium on Antennas and Propagation, ISAP 2016 (Poster 
Presentation) 
Oiendrila Bhowmik Debnath, Kazuyuki Saito, Koichi Ito and Mitsuru Uesaka, “Breast 
cancer treatment using Microwave hyperthermia and Radiation brachytherapy”  
 
Domestic Conference and Proceedings: 
1. National symposium on Advanced Medical Imaging, held in India (Poster 
Presentation) October 2009, Oiendrila Bhowmik, Anburajan “Detection of Breast Cancer 
by Medical Thermography”  
 
2. 19th West Bengal State Science and Technology Congress (WBSSTC), held in India 
(Oral Presentation), March 2012, Oiendrila Bhowmik, Venkatraman Balasubramaniam  
“Detection of Breast cancer from Contra-lateral images” 
 
3. Todai-Seika University (China) Workshop , (Poster Presentation) June, 2015 
Oiendrila Bhowmik Debnath, Kotarou Ushida,  Kazuyuki Saito, Koichi Ito and Mitsuru 
Uesaka “SAR Patterns of Invasive and Non-invasive Antenna Array in Combination of 
Hyperthermia and Radiation Brachytherapy”  
 
4. Japan Society of Maintenology (JSM), (Oral Presentation) July 2016, Oiendrila 
Bhowmik Debnath, Kazuyuki Saito, Koichi Ito and Mitsuru Uesaka  “SAR Patterns of 
Invasive and Non-invasive Antenna Array in Combination of Hyperthermia and Radiation 
Brachytherapy”  
 
5. 21st Annual Meeting of Kantō District Hyperthermia Study Group, March 2017: 
Oiendrila Bhowmik Debnath, Kazuyuki Saito, Koichi Ito and Mitsuru Uesaka  “Treatment 
122 
 
Planning of Combination of Microwave Hyperthermia and Radiation Brachytherapy for 
Bresat Tumor” 
 
 
Awards 
 
1. Best Programmer in Matlab at Bioyantra- National Technical Symposium, August 2009, 
held at India 
 
2. Best Paper Award, National symposium on Advanced Medical Imaging, October 2009, 
held at India 
 
3. Second Best Paper Award at International symposium on Biotech and Global Warming, 
2012 
 
4. Best Original Paper Award (JSM, 2016) 
 
5. Superior research Award (21st Annual Meeting of Kantō District Hyperthermia 
Study Group, 2017) 
 
 
 
 
